WO2011117286A1 - Composés de pyridazine pour lutter contre les ravageurs invertébrés - Google Patents

Composés de pyridazine pour lutter contre les ravageurs invertébrés Download PDF

Info

Publication number
WO2011117286A1
WO2011117286A1 PCT/EP2011/054424 EP2011054424W WO2011117286A1 WO 2011117286 A1 WO2011117286 A1 WO 2011117286A1 EP 2011054424 W EP2011054424 W EP 2011054424W WO 2011117286 A1 WO2011117286 A1 WO 2011117286A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
salts
oxides
compounds
formulae
Prior art date
Application number
PCT/EP2011/054424
Other languages
English (en)
Inventor
Ronan Le Vezouet
Sebastian SÖRGEL
Christian Defieber
Steffen Gross
Karsten KÖRBER
Wolfgang Von Deyn
Douglas D. Anspaugh
Deborah L. Culbertson
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Priority to ES11709439.1T priority Critical patent/ES2589792T3/es
Priority to CN2011800150446A priority patent/CN102812018A/zh
Priority to BR112012023231A priority patent/BR112012023231A2/pt
Priority to EP11709439.1A priority patent/EP2550264B1/fr
Priority to JP2013500489A priority patent/JP2013522347A/ja
Priority to US13/634,899 priority patent/US9040537B2/en
Publication of WO2011117286A1 publication Critical patent/WO2011117286A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines

Definitions

  • the present invention relates to novel pyridazine compounds which are useful for combating or controlling invertebrate pests, in particular arthropod pests.
  • the invention further relates to a method for controlling invertebrate pests by using these compounds.
  • the invention further relates to a method for protecting plant propagation material and/or the plants which grow therefrom by using these compounds.
  • the present invention further relates to plant propagation material and to an agricultural or veterinary composition comprising said compounds.
  • Invertebrate pests and in particular arthropods and nematodes destroy growing and harvested crops and attack wooden dwelling and commercial structures, thereby caus- ing large economic loss to the food supply and to property. While a large number of pesticidal agents are known, due to the ability of target pests to develop resistance to said agents, there is an ongoing need for new agents for combating invertebrate pests such as insects, arachnids and nematodes. It is therefore an object of the present invention to provide compounds having a good pesticidal activity and showing a broad activity spectrum against a large number of different invertebrate pests, especially against difficult to control insects, arachnids and nematodes.
  • WO 2003/106427 describes N-phenyl or N-pyridylcarboxamides of pyrrole- or pyrazole carboxylic acids, which are useful as insecticides.
  • WO 2002/094765 describes N-(6-membered hetaryl) carboxamides of 6-membered heteroaromatic carboxylic acids, which carry an oxazoline or carboxamide radical in the ortho position. The compounds are mentioned to be useful as insecticides.
  • WO 2009/027393 describes N-(3-pyridiyl)carboxamides of substituted pyrazole carboxylic acids, which are useful as insecticides
  • R 1 might be, inter alia, hy- drogen, alkyl, haloalkyl, and the like
  • R 8_A , R 8_c and R 8"D might be, inter alia, hydrogen, halogen, alkyl and triflluoromethyl and R is a radical of the formula
  • EP 332579 discloses fungicidally active N-pyridazinyl carboxamides of 2,6-dihalogen- 4-pyridinecarboxylic acid.
  • EP 480258 discloses, inter alia, N-(4-chloro-6-methylpyridazin-3-yl) 2-(mercaptoethyl)- pyridine-3-ylcarboxamide to be useful for combating endoparasites in warm-blooded animals.
  • the compounds should be useful for protecting plants and plant propagation materials from infestation by invertebrate pests, in particular by insects.
  • the compounds should in particular be useful for application in agriculture.
  • the present invention relates to pyridazine compounds of formulae I or
  • a 1 is N or C-R A1
  • a 2 is N or C-R A2
  • a 3 is N or C-R A3
  • a 4 is N or C-R M
  • a 5 is N or C-R A5
  • R A1 , R A5 are independently of each other selected from hydrogen, halogen, CN, N0 2 , OR a1 , C(Y)R b1 , S(0) m R d1 with m being 0, 1 or 2, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the 3 last mentioned radicals may be unsubstituted or may be partially or fully halogenated,
  • Ci-C 5 -alkylen-C(Y)R b Ci-C 5 -alkylen-C(Y)OR c
  • R A2 , R M are independently of each other selected from hydrogen, halogen, CN, N0 2 , OR a2 , C(Y)R b2 , S(0) m R d2 with m being 0, 1 or 2, Ci-Cio-alkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the 3 last mentioned radicals may be unsubstituted or may be partially or fully halogenated,
  • Ci-Cs-alkylen-CN, Ci-C 5 -alkylen-OR a Ci-Cs-alkylen-CN, Ci-C 5 -alkylen-OR a ,
  • Ci-C 5 -alkylen-C(Y)R b Ci-C 5 -alkylen-C(Y)OR c
  • Ci-C 5 -alkylen-C(Y)R b Ci-C 5 -alkylen-C(Y)OR c
  • W is N or C-R w ;
  • V is N or C-R v ;
  • R 1 and R w are independently of each other selected from hydrogen, halogen, methyl, methoxy, methylthio, methylsulfinyl, methylsulfonyl, Ci-haloalkyl, Ci-haloalkoxy,
  • Ci-haloalkylthio Ci-haloalkylsulfinyl and Ci-haloalkylsulfonyl
  • R u and R v are independently of each other selected from hydrogen, halogen, C1-C4- alkyl, Ci-C3-haloalkyl, Ci-C4-alkoxy, Ci-C3-haloalkoxy,
  • Ci-C 4 -alkylthio Ci-C 3 -haloalkylthio, Ci-C 4 -alkylsulfinyl,
  • Ci-C3-haloalkylsulfinyl Ci-C 4 -alkylsulfonyl
  • Ci-C3-haloalkylsulfonyl Ci-C3-haloalkylsulfonyl
  • X 1 is S, O or NR 1a , wherein
  • R 1a is selected from hydrogen, Ci-Cio-alkyl,
  • C3-Cio-halocycloalkyl C2-Cio-alkenyl, C2-Cio-haloalkenyl, C2-Cio-alkynyl, Ci-Cio-alkoxy-Ci-C4-alkyl, OR a , phenyl, hetaryl, heterocyclyl, phenyl-Ci-C 4 - alkyl, hetaryl-Ci-C 4 -alkyl, heterocyclyl-Ci-C 4 -alkyl wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or substituents which, independently of each other, are selected from halogen, cyano, nitro, Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, Ci-C 4 -alkoxy and C1-C4- haloalkoxy; is OR 2a , NR 2b R 2c , S
  • R 2c are independently of each other selected from hydrogen
  • R 2b and R 2c together with the nitrogen atom to which they are bound form a 5- or 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S and N as a ring member atom and wherein the heterocycle may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which, independently of each other, are selected from halogen, cyano, nitro, Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, Ci-C 4 -alkoxy and C1-C4- haloalkoxy, and wherein
  • R 2d is selected from Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, C3-C6-cycloalkyl,
  • C3-C6-halocycloalkyl C2-C 4 -alkenyl, C2-C 4 -haloalkenyl, C2-C 4 -alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, phenyl, hetaryl, heterocyclyl, phenyl-Ci-C4-alkyl, hetaryl-Ci-C4-alkyl and heterocyclyl-Ci-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which, independently of each other, are selected from halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and C1-C4- haloalkoxy; is hydrogen, CN, Ci-Cio-alkyl, Ci-Cio-haloalkyl
  • Ci-C 5 -alkylen-C(Y)NR 9 R h Ci-C 5 -alkylen-S(0) 2 R d , Ci-C 5 -alkylen-S(0) m NR e R d , C
  • phenyl-Ci-Cs-alkyI hetaryl-Ci-Cs-alkyI, saturated or partially unsaturated hetero- cyclyl-Ci-C5-alkyl, C3-Cio-cycloalkyl-Ci-C5-alkyl and
  • Y is O or S
  • R a , R b , R c are independently of each other selected from hydrogen, Ci-C4-alkyl, C1-C4- haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl,
  • Ci-C4-alkoxy-Ci-C4-alkyl phenyl, hetaryl, heterocyclyl, phenyl-Ci-C4-alkyl, hetaryl-Ci-C4-alkyl and heterocyclyl-Ci-C4-alkyl, wherein the ring in the six last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or substituents which, independently of each other, are selected from halogen, cyano, nitro, Ci-
  • Ci-C4-haloalkyl Ci-C4-alkoxy and Ci-C4-haloalkoxy; is selected from Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl,
  • R e , R f are independently of each other selected from hydrogen, Ci-C4-alkyl,
  • Ci-C4-haloalkyl C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl,
  • Ci-C4-alkoxy-Ci-C4-alkyl Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl,
  • Ci-C4-alkylsulfonyl Ci-C4-haloalkylsulfonyl, phenyl, phenylcarbonyl, phenylsul- fonyl, hetaryl, hetarylcarbonyl, hetarylsulfonyl, heterocyclyl, heterocyclylcarbonyl, heterocyclylsulfonyl, phenyl-Ci-C4-alkyl, hetaryl-Ci-C4-alkyl and heterocyclyl-Ci-
  • C4-alkyl wherein the ring in the twelve last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 substituents which, independently of each other, are selected from halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy and Ci-C4-haloalkoxy; or
  • R e and R f together with the nitrogen atom to which they are bound form a 5- or
  • 6-membered, saturated or unsaturated heterocycle which may carry a further heteroatom being selected from O, S and N as a ring member atom and wherein the heterocycle may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, cyano, nitro, Ci-
  • R9, R h are independently of each other selected from hydrogen, Ci-C4-alkyl,
  • Ci-C4-haloalkyl C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl,
  • Ci-C4-haloalkoxy is selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6- cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl,
  • R a1 , R a2 are independently of each other selected from Ci-C4-alkyl, Ci-C4-haloalkyl, C3- C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4- haloalkenyl, C2-C4-alkynyl and Ci-C4-alkoxy-Ci-C4-alkyl;
  • R b1 , R b2 are independently of each other selected from hydrogen, Ci-C4-alkyl, C1-C4- haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl,
  • C3-C6-halocycloalkyl C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, and Ci-C4-alkoxy-Ci-C4-alkyl;
  • R d1 , R d2 is selected from Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, C 3 -C 6 -cycloalkyl,
  • R a3 has one of the meanings given for R a , except for hydrogen;
  • R b3 has one of the meanings given for R b ;
  • R d3 has one of the meanings given for R d ;
  • Ry is selected from halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl,
  • one of the groups V and W is N, i.e. the heterocycle comprising the groups V and W in the compounds of formulae I and II is selected from pyridazine-3-yl and pyridazine-4-yl.
  • a further aspect of the present invention relates to a method for controlling invertebrate pests which method comprises treating the pests, their food supply, their habitat or their breeding ground or a plant, seed, soil, area, material or environment in which the pests are growing or may grow, or the materials, plants, seeds, soils, surfaces or spaces to be protected from pest attack or infestation with a pesticidally effective amount of a pyridazine compound of formulae I or II according to the present invention or a salt thereof, an N-oxide thereof or a salt of an N-oxide thereof.
  • a further aspect of the present invention relates to a method for protecting plant propagation material and/or the plants which grow therefrom, which method comprises treating the plant propagation material with a pesticidally effective amount of a pyridazine compound of the formulae I or II according to the present invention or an agriculturally acceptable salt thereof, an N-oxide thereof or a salt of an N-oxide thereof.
  • a further aspect of the present invention relates to plant propagation material, comprising at least one compound of formulae I or II according to the present invention and/or an agriculturally acceptable salt thereof, an N-oxide thereof or a salt of an N-oxide thereof.
  • a further aspect of the present invention relates to a method for treating or protecting an animal from infestation or infection by parasites especially ectoparasites which com- prises bringing the animal in contact with a parasiticidally effective amount of a compound of the formulae I or II according to the present invention or a veterinarily acceptable salt or an N-oxide thereof.
  • Bringing the animal in contact with the compound I or II, its salt or the veterinary composition of the invention means applying or administering it to the animal.
  • a further aspect of the present invention relates to an agricultural composition containing at least one compound of formulae I or II according to the present invention and/or an agriculturally acceptable salt or an N-oxide thereof and at least one liquid or solid carrier.
  • the radicals attached to the backbone of the compounds of formulae I or II may con- tain one or more centers of chirality.
  • the compounds of the formulae I or II are present in the form of different enantiomers or diastereomers, depending on the substituents.
  • the present invention relates to every possible stereoisomer of the compounds of formulae I or II , i.e. to single enantiomers or diastereomers, as well as to mixtures thereof.
  • the compounds of formulae I or I I may be amorphous or may exist in one ore more different crystalline states (polymorphs) which may have different macroscopic properties such as stability or show different biological properties such as activities.
  • the pre- sent invention relates to amorphous and crystalline compounds of formulae I or I I , mixtures of different crystalline states of the respective compound I or II , as well as amorphous or crystalline salts thereof.
  • Salts of the compounds of the formulae I or II are preferably agriculturally and veteri- narily acceptable salts. They can be formed in a customary manner, e.g. by reacting the compound with an acid of the anion in question if the compound of formulae I or II has a basic functionality.
  • Agriculturally useful salts of the compounds of formulae I and I I encompass especially the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the pesticidal action of the compounds of formulae I or I I .
  • Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogen- sulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicar- bonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting compounds of formulae I and I I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.
  • Veterinarily acceptable salts of the compounds of formulae I and I I encompass especially the acid addition salts which are known and accepted in the art for the formation of salts for veterinary use.
  • Suitable acid addition salts e.g. formed by compounds of formulae I or II containing a basic nitrogen atom, e.g. an amino group, include salts with inorganic acids, for example hydrochlorids, sulphates, phosphates, and nitrates and salts of organic acids for example acetic acid, maleic acid, e.g. the monoacid salts or diacid salts of maleic acid, dimaleic acid, fumaric acid, e.g. the monoacid salts or diacid salts of fumaric acid, difumaric acid, methane sulfenic acid, methane sulfonic acid, and succinic acid.
  • inorganic acids for example hydrochlorids, sulphates, phosphates, and nitrate
  • N-oxide includes any compound of formulae I or II which has at least one tertiary nitrogen atom that is oxidized to an N-oxide moiety.
  • invertebrate pest encompasses animal populations, such as insects, arachnids and nematodes. These pests may attack plants thereby causing substantial damage to the plants attacked.
  • animal pest as used herein also encompasses ectoparasites which may infest animals, in particular warm blooded animals such as e.g. mammals or birds, or other higher animals such as reptiles, amphibi- ans or fish, thereby causing substantial damage to the animals infested.
  • plant propagation material includes all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants. Seedlings and young plants, which are to be transplanted after germination or after emergence from soil, may also be included. These plant propagation materials may be treated prophylactically with a plant protection compound either at or before planting or transplanting.
  • plants comprises any types of plants including “non-cultivated plants” and in particular "cultivated plants”.
  • non-cultivated plants refers to any wild type species or related species or related genera of a cultivated plant.
  • cultiva plants as used herein includes plants which have been modified by breeding, mutagenesis or genetic engineering.
  • Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination.
  • one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant.
  • Such genetic modifications also include but are not limited to targeted post-transtional modification of protein(s) (oligo- or polypeptides), for example by glycosylation or polymer additions such as prenylated, acetylated or farne- sylated moieties or PEG moieties (e.g. as disclosed in Biotechnol Prog. 2001 Jul- Aug;17(4):720-8., Protein Eng. Des. Sel. 2004 Jan;17(1 ):57-66, Nat. Protoc.
  • cultiva plants as used herein further includes plants that have been rendered tolerant to applications of specific classes of herbicides, such as hy- droxy-phenylpyruvate dioxygenase (HPPD) inhibitors; acetolactate synthase (ALS) inhibitors, such as sulfonyl ureas (see e. g. US 6,222,100, WO 01/82685, WO
  • specific classes of herbicides such as hy- droxy-phenylpyruvate dioxygenase (HPPD) inhibitors; acetolactate synthase (ALS) inhibitors, such as sulfonyl ureas (see e. g. US 6,222,100, WO 01/82685, WO
  • EP-A-0242236, EP-A-242246) or oxynil herbicides see e. g. US 5,559,024) as a result of conventional methods of breeding or genetic engineering.
  • mutagenesis for example Clearfield ® summer rape (Canola) being tolerant to imidazolinones, e. g. imazamox.
  • cultiva plants as used herein further includes plants that are by the use of recombinant DNA techniques capable to synthesize one or more insecticidal pro- teins, especially those known from the bacterial genus bacillus, particularly from bacillus thuringiensis, such as endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), Cry- IIA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, for example Photorhabdus spp.
  • endotoxins e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), Cry- IIA(b), CrylllA, CrylllB(bl ) or Cry9c
  • VIP vegetative
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins
  • toxins produced by fungi such Streptomycetes toxins, plant lectins, such as pea or barley lectins; agglutinins
  • proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors
  • ribosome-inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase
  • ion channel blockers such as blockers of sodium or calcium channels
  • these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins.
  • Hybrid proteins are characterized by a new combination of protein domains, (see, for example WO 02/015701 ).
  • Further examples of such toxins or genetically-modified plants capable of synthesizing such toxins are dis-closed, for ex- ample, in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/018810 und WO 03/052073.
  • the methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.
  • insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins protection from harmful pests from certain taxonomic groups of arthropods insects, particularly to beetles (Coleoptera), flies (Diptera), and butterflies and moths (Lepidoptera) and to plant parasitic nematodes (Nematoda).
  • cultivars as used herein further includes plants that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral or fungal pathogens.
  • proteins are the so-called "pathogenesis-related proteins" (PR proteins, see, for example EP-A 0 392 225), plant disease resistance genes (for example potato cultivars, which express resistance genes acting against Phytophthora in- festans derived from the mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora).
  • PR proteins pathogenesis-related proteins
  • plant disease resistance genes for example potato cultivars, which express resistance genes acting against Phytophthora in- festans derived from the mexican wild potato Solanum bulbocastanum
  • T4-lysozym e. g. potato cultivar
  • cultivadas plants as used herein further includes plants that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting envi- ron-mental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.
  • cultiva plants as used herein further includes plants that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, for ex-ample oil crops that produce health-promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera ® rape).
  • cultivated plants as used herein further includes plants that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, for example potatoes that produce increased amounts of amylopectin (e. g. Amflora ® potato).
  • the organic moieties mentioned in the above definitions of the variables are - like the term halogen - collective terms for individual listings of the individual group members.
  • the prefix C n -C m indicates in each case the possible number of carbon atoms in the group.
  • the term halogen denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.
  • alkyl as used herein and in the alkyl moieties of alkoxy, alkylcarbonyl, alkyl- thio, alkylsulfinyl, alkylsulfonyl and alkoxyalkyi denotes in each case a straight-chain or branched alkyl group having usually from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms and in particular from 1 to 3 carbon atoms.
  • Examples of an alkyl group are methyl, ethyl, n-propyl, iso-propyl, n-butyl,
  • alkylene (or alkanediyl) as used herein in each case denotes an alkyl radical as defined above, wherein one hydrogen atom at any position of the carbon back- bone is replaced by one further binding site, thus forming a bivalent moiety.
  • haloalkyl as used herein and in the haloalkyl moieties of haloalkoxy, haloal- kylthio, haloalkylcarbonyl, haloalkylsulfonyl and haloalkylsulfinyl, denotes in each case a straight-chain or branched alkyl group having usually from 1 to 10 carbon atoms, fre- quently from 1 to 6 carbon atoms, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms.
  • Preferred haloalkyl moieties are selected from Ci-C4-haloalkyl, more preferably from Ci-C2-haloalkyl, in particular from
  • Ci-C2-fluoroalkyl such as fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, and the like.
  • alkoxy denotes in each case a straight-chain or branched alkyl group which is bound via an oxygen atom and has usually from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms.
  • alkoxy group examples are methoxy, ethoxy, n-propoxy, iso-propoxy, n-butyloxy,
  • haloalkoxy denotes in each case a straight-chain or branched alkoxy group having from 1 to 10 carbon atoms, frequently from 1 to 4 carbon atoms, preferably 1 to 3 carbon atoms, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms, in particular fluorine atoms.
  • Preferred haloalkoxy moieties include Ci-C4-haloalkoxy, in particular Ci-C2-fluoroalkoxy, such as fluoromethoxy, difluoromethoxy, trifluoromethoxy, 1 -fluoroethoxy, 2-fluoroethoxy,
  • cycloalkyl as used herein and in the cycloalkyl moieties of cycloalkoxy and cycloalkylmethyl denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 10 carbon atoms or 3 to 6 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.1.1 ]hexyl, bicy- clo[3.1 .1 ]heptyl, bicyclo[2.2.1 ]heptyl, and bicyclo[2.2.2]octyl.
  • halocycloalkyl as used herein and in the halocycloalkyl moieties of halo- cycloalkylmethyl denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 10 carbon atoms or 3 to 6 carbon atoms, wherein at least one, e.g. 1 , 2, 3, 4 or 5 of the hydrogen atoms are replaced by halogen, in particular by fluorine or chlorine. Examples are 1 - and 2- fluorocyclopropyl, 1 ,2-, 2,2- and
  • alkenyl denotes in each case a singly unsaturated hydrocar- bon radical having usually 2 to 10, preferably 2 to 4 carbon atoms, e.g. vinyl, allyl (2-propen-1 -yl), 1 -propen-1 -yl, 2-propen-2-yl, methallyl (2-methylprop-2-en-1 -yl), 2-buten-1 -yl, 3-buten-1 -yl, 2-penten-1 -yl, 3-penten-1 -yl, 4-penten-1 -yl, 1 -methylbut-2- en-1 -yl, 2-ethylprop-2-en-1 -yl and the like.
  • alkynyl denotes in each case a singly unsaturated hydrocarbon radical having usually 2 to 10, preferably 2 to 4 carbon atoms, e.g. ethynyl, propargyl (2-propyn-1 -yl), 1 -propyn-1 -yl, 1 -methylprop-2-yn-1 -yl), 2-butyn-1 -yl, 3-butyn-
  • alkoxyalkyl refers to alkyl usually comprising 1 to 4 carbon atoms, wherein 1 carbon atom carries an alkoxy radical usually comprising 1 to 10, in particular 1 to 4, carbon atoms as defined above. Examples are CH2OCH3, CH2-OC2H5, n-propoxymethyl, CH2-OCH(CH3)2, n-butoxymethyl, (l -methylpropoxy)-methyl,
  • haloalkylcarbonyl refers to an alkylcarbonyl group as defined above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
  • alkylthio (also alkylsulfanyl or alkyl-S-)" as used herein refers to a straight- chain or branched saturated alkyl group comprising 1 to 10 carbon atoms
  • haloalkylthio refers to an alkylthio group as defined above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bro- mine and/or iodine.
  • Ci-C4-alkylsulfinyl attached through the sulfur atom of the sulfinyl group at any position in the alkyl group.
  • haloalkylsulfinyl refers to an alkylsulfinyl group as defined above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
  • alkylsulfonyl refers to a straight-chain or branched saturated alkyl group comprising 1 to 10 carbon atoms
  • haloalkylsulfonyl refers to an alkylsulfonyl group as defined above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
  • heterocyclyl includes in general 3-, 4-, 5-, 6-, 7- or 8- membered, in particular 5-, 6-, 7- or 8-membered monocyclic heterocyclic non-aromatic radicals and 8 to 10 membered bicyclic heterocyclic non-aromatic radicals, the mono- and bicyclic non- aromatic radicals may be saturated or unsaturated.
  • the mono- and bicyclic heterocyclic non-aromatic radicals usually comprise 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring members, where S-atoms as ring members may be present as S, SO or SO2.
  • saturated or unsaturated 3-, 4-, 5-, 6-, 7- or 8-membered heterocyclic radicals comprise saturated or unsaturated, non-aromatic heterocyclic rings, such as oxiranyl, oxetanyl, thietanyl, thietanyl-S-oxid (S-oxothietanyl), thietanyl-S-dioxid (S- dioxothiethanyl), pyrrolidinyl, pyrazolinyl, imidazolinyl, pyrrolinyl, pyrazolinyl, imida- zolinyl, tetrahydrofuranyl, dihydrofuranyl, 1 ,3-dioxolanyl, dioxolenyl, thiolanyl,
  • heterocyclic ring also comprising 1 or 2 carbonyl groups as ring members comprise pyrrolidin-2-onyl, pyrrolidin- 2,5-dionyl, imidazolidin-2-onyl, oxazolidin-2-onyl, thiazolidin-2-onyl and the like.
  • heteroaryl includes in general 5- or 6-membered unsaturated monocyclic heterocyclic radicals and 8 to 10 membered unsaturated bicyclic heterocyclic radicals which are aromatic, i.e. they comply with Huckel's rule (4n+2 rule). Hetaryl usually comprise 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring members.
  • heteroaryl includes monocyclic 5- or 6-membered heteroaromatic radicals comprising as ring members 1 , 2, 3 or 4 heteroatoms selected from N, O and S.
  • 5- or 6-membered heteroaromatic radicals include pyridyl, i.e. 2-, 3-, or 4-pyridyl, pyrimidinyl, i.e. 2-, 4- or 5-pyrimidinyl, pyrazinyl, pyridazinyl, i.e. 3- or
  • 5- [1 ,3,4]oxadiazolyl 4- or 5-(1 ,2,3-oxadiazol)yl, 3- or 5-(1 ,2,4-oxadiazol)yl, 2- or 5-(1 ,3,4-thiadiazol)yl, thiadiazolyl, e.g. 2- or 5-(1 ,3,4-thiadiazol)yl, 4- or
  • heteroaryl also includes bicyclic 8- to 10-membered heteroaromatic radicals comprising as ring members 1 , 2 or 3 heteroatoms selected from N, O and S, wherein a 5- or 6-membered heteroaromatic ring is fused to a phenyl ring or to a 5- or
  • 6- membered heteroaromatic radical examples include benzofuranyl, benzothienyl, indolyl, indazolyl, benzimidazolyl, benzoxathiazolyl, ben- zoxadiazolyl, benzothiadiazolyl, benzoxazinyl, chinolinyl, isochinolinyl, purinyl,
  • fused hetaryl radicals may be bonded to the remainder of the molecule via any ring atom of 5- or 6-membered heteroaromatic ring or via a carbon atom of the fused phenyl moiety.
  • a first preferred embodiment of the invention relates to the pyridazine compounds of the formula I, to their salts, to their N-oxides and to the salts of their N-oxides.
  • R 1 is selected from hydrogen, CN , Ci-Cio-alkyl, Ci-Cio-haloalkyl, C2- Cio-alkenyl, C 2 -Cio-haloalkenyl, C 2 -Cio-alkynyl, Ci-C 4 -alkylene-CN , Ci-C 5 -alkylen-OR a , phenyl-Ci-C5-alkyl, hetaryl-d-Cs-alkyl, heterocyclyl-d-Cs-alkyl, C3-Cio-cycloalkyl-Ci- Cs-alkyl, Ci-C 5 -alkylen-C(Y)R b , Ci-C 5 -alkylen-C(Y)OR c , OR a , C(Y)R b , C(Y)OR c and S(0)2R d
  • radicals R 1 examples include:
  • Ci-C4-alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, tert. -butyl or 2- methylpropyl;
  • Ci-C4-haloalkyl such as 2-fluoroethyl, 2-chloroethyl, 2-bromethyl, 2,2- difluoroethyl, 2,2-dichloroethyl, 2,2-dibromoethyl or 2,2,2-trifluoroethyl;
  • Ci-C4-alkylene-CN such as cyanomethyl or cyanoethyl
  • Ci-C4-alkylen-OR a such as methoxymethyl, ethoxymethyl 2-methoxyethyl, 2- ethoxyethyl, difluoromethoxymethyl, trifluoromethoxymethyl, 2- difluoromethoxyethyl or 2-trifluoromethoxyethyl;
  • Ci-C 4 -alkylen-NR e R f such as 2-(dimethylamino)ethyl
  • Ci-C4-alkylen-C(Y)NR9R h such as ⁇ , ⁇ -dimethylcarbamoylmethyl or N,N- dimethylthiocarbamoylmethyl
  • C3-C6-cycloalkyl such as cyclopropyl, cyclobutyl or cyclopentyl
  • heterocyclyl wherein the heterocyclyl radicals may be unsubstituted or may carry 1 , 2 or 3 radicals R as defined above, e.g. oxetan-2-yl, oxetan-3-yl, oxolan-2-yl, oxolan-3-yl, thietan-3-yl or 1 , 1 -dioxathietan-3-yl;
  • C3-C6-cycloalkyl-Ci-C4-alkyl in particular C3-C6-cycloalkylmethyl, I -C3-C6- cycloalkylethyl or 2-C3-C6-cycloalkylethyl such as cyclopropylmethyl, cyclobutyl- methyl or cyclopentylmethyl;
  • phenyl-Ci-C4-alkyl in particular benzyl, 1 -phenylethyl or 2-phenylethyl, wherein the phenyl radicals may be unsubstituted or may carry 1 , 2 or 3 radicals R as defined above, e.g. benzyl;
  • heterocyclyl-Ci-C4-alkyl in particular heterocyclylmethyl, 1 -heterocyclylethyl or 2- heterocyclylethyl, wherein the heterocyclyl radicals may be unsubstituted or may carry 1 , 2 or 3 radicals R as defined above, e.g.
  • hetaryl-Ci-C4-alkyl in particular hetarylmethyl, 1 -hetarylethyl or 2-hetarylethyl, wherein the hetarclyl radicals may be unsubstituted or may carry 1 , 2 or 3 radicals R y as defined above, e.g.
  • R 1 is selected from hydrogen, Ci-Cio-alkyl, Ci-Cio-haloalkyl, C1-C4- alkylene-CN, Ci-C 5 -alkylen-OR a , hetaryl-Ci-C 5 -alkyl, heterocyclyl-Ci-C 5 -alkyl and C 3 - Cio-cycloalkyl-Ci-C5-alkyl, wherein R a is as defined herein and is preferably selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl, and more preferably from hydrogen, methyl, ethyl, difluoromethyl and trifluoromethyl.
  • R 1 is selected from hydrogen, Ci-C3-alkyl, Ci-C3-haloalkyl and C1-C3- alkoxy-Ci-C3-alkyl.
  • Another embodiment of the invention relates to pyridazine compounds of the formula II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds.
  • R 2a and R 2d are preferably Ci-C4-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, C2-C4- cycloalkylmethyl or Ci-C4-alkoxy-Ci-C4-alkyl.
  • R 2b and R2 C are preferably selected, independently of each other, from Ci-C4-alkyl, C3-C6-cycloalkyl or Ci-C4-alkoxy-Ci-C4-alkyl or R 2b and R 2c , together with the nitrogen atom to which they are attached, form a saturated, nitrogen-bound 5- or 6-membered heterocycle which may comprise a further heteroatom selected from O, S and N, e.g. NR 2b R 2c being 1-pyrrolidinyl, 1-piperidinyl, 1-piperazinyl, 4-morpholinyl or 4-thiomorpholinyl.
  • R 1 , R u , R v and R w are selected independently of each other from hydrogen, fluorine, bromine, chlorine, methyl, difluoromethyl, trifluoromethyl, methoxy, difluoromethoxy or trifluoromethoxy. More preferably at least two of the radicals R 1 , R u , R v or R w , if present, are hydrogen, and most particularly R 1 , R u , R v and R w , if present, are hydrogen, i.e. one of the groups V and W is N and the other CH.
  • W is CH
  • the radical R u is selected from hydrogen, halogen, methyl, difluoromethyl, trifluoromethyl, methoxy, difluoromethoxy and trifluoromethoxy, and preferably is hydrogen.
  • R u is selected from hydrogen, halogen, methyl, difluoromethyl, trifluoromethyl, methoxy, difluoromethoxy and trifluoromethoxy, and preferably is hydrogen.
  • R 1 has one of the preferred meanings and wherein R 1 is in particular selected from hydrogen, Ci-Cio-alkyl, C1-C10- haloalkyl, Ci-C 4 -alkylene-CN, Ci-C 5 -alkylen-OR a , hetaryl-Ci-C 5 -alkyl, heterocyclyl-Ci- Cs-alkyl and C3-Cio-cycloalkyl-Ci-C5-alkyl, wherein R a is as defined herein and is preferably selected from hydrogen, Ci-C 4 -alkyl, Ci-C 4 -haloalkyl and Ci-C 4 -alkoxy-Ci-C2- alkyl, and more preferably from hydrogen, methyl, ethyl, difluoromethyl and trifluoromethyl.
  • R 1 in formula I.A is selected from hydrogen, Ci-C3-alkyl
  • heterocycle of the radical A comprises 1 , 2 or 3 of the variables A 1 , A 2 , A 3 , A 4 or A 5 are N and the remaining groups are C-R A1 , C-R A2 , C-R A3 , C-R M or C-R A5 .
  • Examples of such compounds are compounds of formulae I or I I , wherein the heterocycle A is selected from the radicals pyrazine-2-yl, pyridazine-3-yl, pyridazine-4- yl, pyrimidine-5-yl, pyrimidine-4-yl, pyrimidine-2-yl, 1 ,2,3-triazine-4-yl, 1 ,2,3-triazine-5- yl, 1 ,2,4-triazine-3-yl, 1 ,2,4-triazine-5-yl and 1 ,2,4-triazine-6-yl, wherein these radicals are substituted with variables R A1 , R A2 , R A3 , R M and R A5 at their respective carbon atoms.
  • the heterocycle of the radical A comprises 1 or 2 of the variables A 1 , A 2 , A 3 , A 4 or A 5 are N and the remaining groups are C-R A1 , C-R A2 , C-R A3 , C-R M or C- R A5 .
  • Examples of such compounds are compounds of formulae I or I I , wherein the heterocycle A is selected from the radicals pyrazine-2-yl, pyridazine-3-yl, pyridazine-4-yl, pyrimidine-5-yl, pyrimidine-4-yl and pyrimidine-2-yl, wherein these radicals are substi- tuted with variables R A1 , R A2 , R A3 , R M and R A5 at their respective carbon atoms.
  • R A1 and R A5 are are different from a radical SR d1 , and wherein R A1 and R A5 are preferebly selected independently of each other from hydro- gen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, d-Cs-alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C 5 -alkylen- C(Y)OR c
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, d-Cs-alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyi and het- erocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-halo
  • R A1 and R A5 are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, di- fluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, methoxy- methyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 and R A4 are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN , C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , Ci-C 5 -alkylen-C(Y)OR c , C 3
  • R A2 and R M are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C3- alkylen-CN, Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents R , wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C
  • R A2 and R M are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, di- fluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, methoxy- methyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b ,
  • Ci-C5-alkylen-C(Y)OR c C 3 -Cio-cycloalkyl, Cs-Cio-cycloalkenyl, saturated or partially unsaturated 3 to 1 0 membered heterocyclyl, C 3 -Cio-cycloalkyl-Ci-C5-alkyl, C5-C10- cycloalkenyl-Ci-C5-alkyl and 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, wherein cycloalkyl, cycloalkenyl and heterocyclyl in the 6 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein Y is defined herein and in particular is oxygen, wherein R a , R b and R c are as defined herein and in particular are selected independently of each other from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-hal
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, C1-C4- haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN, Ci-C 3 -alkylen-OR a , C3-C7- cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl- Ci-C3-alkyl, wherein cycloalkyi and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents R , wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl,
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and I I , to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-1 ,
  • R A5 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN , C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C 5 -alkylen-C(Y)OR c , C 3 -Cio-cycloalkyl, C 5 - Cio-cycloalkenyl, saturated or unsaturated 3-
  • R A5 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A5 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 and R A4 are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN, C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , Ci-C 5 -alkylen-C(Y)OR c ,
  • R A2 and R M are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-Cs-alkylen- CN, Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7- membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy- Ci
  • R A2 and R M are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • substituents R A2 , R A4 and R A5 are hydrogen.
  • suitable radicals A-1 are the radicals of formulae A-1 .1 to A-1 .173, as defined in Table A1 .
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-2,
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C5-alkylen-C(Y)OR c , C3-Cio-cycloalkyl, Cs-do-cycloalkenyl, saturated
  • R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl, and specifically from the group consisting of hydrogen, methyl, ethyl, difluormethyl and trifluoromethyl, and wherein the substituents Ry are as defined herein and in particular are selected independently of each other from
  • R A1 and R A5 are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN, NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN, Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b ,
  • Ci-C5-alkylen-C(Y)OR c C3-Cio-cycloalkyl, Cs-do-cycloalkenyl, saturated or partially unsaturated 3 to 10 membered heterocyclyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C5-C10- cycloalkenyl-Ci-C5-alkyl and 3- to 10-membered heterocyclyl-d-Cs-alkyl, wherein cycloalkyl, cycloalkenyl and heterocyclyl in the 6 last mentioned radicals may be un- substituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein Y is defined herein and in particular is oxygen, wherein R a , R b and R c are as defined herein and in particular are selected independently of each other from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN, Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • substituents R A1 , R A3 and R A5 are hydrogen.
  • suitable radicals A-1 are the radicals of formulae A-2.1 to A-2.131 , as defined in Table A2. Table A2.
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-3,
  • R A2 and R M are selected independently of each other from hydrogen, halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN , C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , Ci-C 5 -alkylen-C(Y)OR c , C 3 -
  • R A2 and R A4 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 3 -alkylen- CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7- membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alk
  • R A2 and R A4 are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b ,
  • Ci-C5-alkylen-C(Y)OR c C3-Cio-cycloalkyl, Cs-Cio-cycloalkenyl, saturated or partially unsaturated 3 to 10 membered heterocyclyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C5-C10- cycloalkenyl-Ci-C5-alkyl and 3- to 10-membered heterocyclyl-d-Cs-alkyl, wherein cycloalkyl, cycloalkenyl and heterocyclyl in the 6 last mentioned radicals may be un- substituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein Y is defined herein and in particular is oxygen, wherein R a , R b and R c are as defined herein and in particular are selected independently of each other from the group con- sisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl,
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • one or two of the substituents R A2 , R A3 and R A4 are hydrogen.
  • radicals A-3 are the radicals of formulae A-3.1 to A-3.13, as defined in Table A3. Table A3.
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-4,
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN, Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C5-alkylen-C(Y)OR c , C3-Cio-cycloalkyl, Cs-do-cycloalkenyl, saturated or
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy,
  • R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl, and specifically from the group consisting of hydrogen, methyl, ethyl, difluormethyl and trifluoromethyl, and wherein the substituents Ry are as defined herein and in particular are selected independently of each other from
  • R A1 and R A5 are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 and R A4 are selected independently of each other from hydrogen, halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN, C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , Ci-C 5 -alkylen-C(Y)OR c , C 3
  • R A2 and R A4 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 3 -alkylen- CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7- membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alk
  • R A2 and R A4 are selected independently of each other from hy- drogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A1 , R A2 , R A4 and R A5 are hydrogen.
  • radicals A-4 are the radicals of formulae A-4.1 to A-4.10, as defined in Table A4. Table A4.
  • A-4.1 Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and I I , to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-5,
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C5-alkylen-C(Y)
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy,
  • R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl, and specifically from the group consisting of hydrogen, methyl, ethyl, difluormethyl and trifluoromethyl, and wherein the substituents Ry are as defined herein and in particular are selected
  • R A1 and R A5 are selected independently of each other from hy- drogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , C1-C5- alkylen-C(Y)OR c , C 3 -Ci
  • R A2 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A2 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b ,
  • Ci-C5-alkylen-C(Y)OR c C3-Cio-cycloalkyl, Cs-Cio-cycloalkenyl, saturated or partially unsaturated 3 to 10 membered heterocyclyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C5-C10- cycloalkenyl-Ci-C5-alkyl and 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, wherein cycloalkyl, cycloalkenyl and heterocyclyl in the 6 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein Y is defined herein and in particular is oxygen, wherein R a , R b and R c are as defined herein and in particular are selected independently of each other from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN, Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A1 , R A2 , R A3 and R A5 are hydrogen.
  • radicals A-5 are the radicals of formulae A-5.1 to A-5.37, as defined in Table A5.
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-6,
  • R A1 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN , C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C 5 -alkylen-C(Y)OR c , C 3 -Cio-cycloalkyl, C 5 - Cio-cycloalkenyl, saturated or unsaturated 3- to
  • R A1 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl
  • R A1 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 and R M are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN , C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , Ci-C 5 -alkylen-C(Y)OR c , C
  • R A2 and R A4 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 3 -alkylen- CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7- membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alk
  • R A2 and R M are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b ,
  • Ci-C5-alkylen-C(Y)OR c C3-Cio-cycloalkyl, Cs-Cio-cycloalkenyl, saturated or partially unsaturated 3 to 10 membered heterocyclyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C5-C10- cycloalkenyl-Ci-C5-alkyl and 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, wherein cycloalkyl, cycloalkenyl and heterocyclyl in the 6 last mentioned radicals may be un- substituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein Y is defined herein and in particular is oxygen, wherein R a , R b and R c are as defined herein and in particular are selected independently of each other from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • two or three of the substituents R A1 , R A2 , R A3 and R M are hydrogen.
  • radicals A-6 are the radicals of formulae A-6.1 to A-6.31 , as defined in Table A6. Table A6.
  • A-6.31 Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and I I , to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-7,
  • R A1 and R A5 are as defined herein.
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C5-alkylen-C(Y)OR c ,
  • R A1 and R A5 are selected independently of each other from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 3 -alkylen- CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C 3 -C 7 -cycloalkyl-Ci-C 3 -alkyl, and 3- to 7- membered saturated heterocyclyl-Ci-C 3 -alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alk
  • R A1 and R A5 are selected independently of each other from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, iso- butyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2,2-trifluoroethyl, methoxymethyl, difluoromethoxymethyl, trifluorometh- oxymethyl, cyanomethyl, 2-methoxy-1 -ethyl, 2-difluoromethoxy-1 -ethyl, 2- trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , C1-C5- alkylen-C(Y)OR c , C 3 -Ci
  • R A2 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN, Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A2 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A1 , R A2 and R A5 are hydrogen.
  • radicals A-7 are the radicals of formulae A-7.1 to A-7.19, as defined in Table A7.
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-8,
  • R A1 is selected from hydrogen, halogen, CN, NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C 4 -alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN, C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C 5 -alkylen-C(Y)OR c , C 3 -Cio-cycloalkyl, C 5 - Cio-cycloalkenyl, saturated or unsaturated 3- to 10-member
  • R A1 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl
  • R A1 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , C1-C5- alkylen-C(Y)OR c , C3-Cio
  • R A2 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl
  • R A2 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b ,
  • Ci-C5-alkylen-C(Y)OR c C3-Cio-cycloalkyl, Cs-Cio-cycloalkenyl, saturated or partially unsaturated 3 to 10 membered heterocyclyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C5-C10- cycloalkenyl-Ci-C5-alkyl and 3- to 10-membered heterocyclyl-Ci-Cs-alkyl, wherein cycloalkyl, cycloalkenyl and heterocyclyl in the 6 last mentioned radicals may be un- substituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein Y is defined herein and in particular is oxygen, wherein R a , R b and R c are as defined herein and in particular are selected independently of each other from the group consisting of hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN, Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • one or two of the substituents R A1 , R A2 and R A3 are hydrogen.
  • radicals A-8 are the radicals of formulae A-8.1 to A-8.30, as defined in Table A8.
  • Another preferred embodiment of the invention relates to pyridazine compounds of the formulae I and II, to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof and to the methods and uses of such compounds, wherein X 1 , X 2 , R 1 , R 1 , R u , W and V are as defined above and in particular have one of the preferred meanings and wherein A is a radical A-9,
  • R A5 is selected from hydrogen, halogen, CN, NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, Ci-Cs-alkylen-CN , C1-C5- alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b and Ci-C 5 -alkylen-C(Y)OR c , C 3 -Cio-cycloalkyl, C 5 - Cio-cycloalkenyl, saturated or unsaturated 3- to 10-member
  • R A5 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A5 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A2 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , C1-C5- alkylen-C(Y)OR c , C3-Cio
  • R A2 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl,
  • R A2 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • R A3 is selected from hydrogen, halogen, CN , NO2, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl, Ci-C 5 -alkylen-CN , Ci-C 5 -alkylen-OR a , Ci-C 5 -alkylen-C(Y)R b , Ci-C5-alkylen-C(Y)OR c , C3-Cio-cycl
  • R A3 is selected from hydrogen, halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C 4 -alkoxy, Ci-C 4 -haloalkoxy, Ci-C 3 -alkylen-CN , Ci-C 3 -alkylen-OR a , C 3 -C 7 -cycloalkyl, C3-C7-cycloalkyl-Ci-C3-alkyl, and 3- to 7-membered saturated heterocyclyl-Ci-C3-alkyl, wherein cycloalkyl and heterocyclyl in the 3 last mentioned radicals may be unsubsti- tuted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, wherein R a is as defined herein and in particular is selected from the group consisting of hydrogen, Ci- C4-alkyl, Ci-C4-haloalkyl and Ci-C4-alkoxy-Ci-C2-alkyl
  • R A3 is selected from hydrogen, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, isopropyl, cyclopropyl, isobutyl, cyclopropylmethyl, fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl, meth- oxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, cyanomethyl, 2-methoxy-1 - ethyl, 2-difluoromethoxy-1 -ethyl, 2-trifuoromethoxy-1 -ethyl, and 2-cya no- 1 -ethyl.
  • one or two of the substituents R A2 , R A3 and R A5 are hydrogen.
  • radicals A-9 are the radicals of formulae A-9.1 to A-9.25, as defined in Table A9.
  • a very preferred embodiment of the invention relates to compounds of the formula I and to the salts thereof, the N-oxides thereof and the salts of the N-oxides thereof, wherein X 1 is O. These compounds are hereinafter also referred to as compounds ⁇
  • A is a radical selected from the radicals A-1 , A-2, A-3, A-4, A-5, A-6, A-7, A-8 and A-9, and particularly selected from the radicals A-1 .1 to A-1 .173, A-2.1 to A-2.131 , A-3.1 to A-3.13, A-4.1 to A-4.10, A-5.1 to A-5.37, A-6.1 to A-6.31 , A-7.1 to A- 7.19, A-8.1 to A-8.30 and A-9.1 to A-9.25.
  • A is a radical selected from the radicals A-1 , A-2 and A-3, and particularly selected from the radicals A-1 .1 to A-1 .173, A-2.1 to A-2.131 and A-3.1 to A-3.13.
  • a particularly preferred embodiment of the invention relates to compounds of formula ⁇ that are selected from compounds of the formluae I'.A and I'.B, including their salts, their and N-oxides and the salts of their N-oxides,
  • the radical R 1 is preferably selected from the group consisting of hydrogen, CN , Ci-Cio-alkyl, Ci-Cio-haloalkyl, C2-Cio-alkenyl, C2-Cio-haloalkenyl, C 2 -Cio-alkynyl, Ci-C 4 -alkylene-CN , OR a , C(Y)R b , C(Y)OR c , S(0) 2 R d , Ci-C 4 -alkylen- C(Y)R b , Ci-C 4 -alkylen-OR a , Ci-C 4 -alkylen-NR e R f , Ci-C 4 -alkylen-C(Y)N R9Rh, phenyl-Ci- C 4 -alkyl, heterocyclyl-Ci-C 4 -alkyl and hetaryl-Ci-C 4
  • R a , R b , R c , R e and R f are as defined herein; and in particular selected from the group consisting of hydrogen, Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, Ci-C 4 -alkoxy-Ci-C 4 -alkyl, heterocyclyl-Ci-C 4 -alkyl and hetaryl-Ci-C 4 -alkyl; more preferably from the group consisting of hydrogen, Ci-C 4 -alkyl and Ci-C 4 -alkoxy-Ci-C2-alkyl, most preferably from the group consisting of hydrogen, methyl and ethyl, and wherein R d is as defined herein; and in particular selected from the group consisting of Ci-C 4 -alkyl, Ci-C 4 -haloalkyl, Ci- C4-alkoxy-Ci-C4-alkyl, heterocyclyl-Ci-C4-alkyl
  • R 1 is in particular selected from hydrogen, Ci- Cio-alkyl, Ci-Cio-haloalkyl, Ci-C 4 -alkylene-CN , Ci-C 5 -alkylen-OR a , hetaryl-Ci-C 5 -alkyl, heterocyclyl-Ci-C5-alkyl and C3-Cio-cycloalkyl-Ci-C5-alkyl, wherein R a is as defined herein and is preferably selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and Ci- C4-alkoxy-Ci-C2-alkyl, and more preferably from hydrogen, methyl, ethyl, difluoromethyl and trifluoromethyl.
  • the radical R 1 is especially selected from hydrogen, C1-C3- alkyl, Ci-C3-haloalkyl and Ci-C3-alkoxy-Ci-C3-alkyl.
  • the radical A has the aforementioned meanings, in particular a preferred meaning.
  • the radical A is preferably a radical selected from the radicals A-1 , A-2, A-3, A-4, A-5, A-6, A-7, A-8 and A-9, and particularly selected from the radicals A-1 .1 to A-1 .173, A-2.1 to A-2.131 , A-3.1 to A-3.13, A- 4.1 to A-4.10, A-5.1 to A-5.37, A-6.1 to A-6.31 , A-7.1 to A-7.19, A-8.1 to A-8.30 and A- 9.1 to A-9.25.
  • A is a radical selected from the radicals A- 1 , A-2 and A-3, and particularly selected from the radicals A-1 .1 to A-1 .173, A-2.1 to A- 2.131 and A-3.1 to A-3.13.
  • Examples of compounds of this particularly preferred embodiment are the compound given in the following tables 1 to 469.
  • Table 1 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 and R 1 has one of the meanings given in Table B.
  • Table 2 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .2 and R 1 has one of the meanings given in Table B.
  • Table 3 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .3 and R 1 has one of the meanings given in Table B.
  • Table 4 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .4 and R 1 has one of the meanings given in Table B.
  • Table 5 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .5 and R 1 has one of the meanings given in Table B.
  • Table 6 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .6 and R 1 has one of the meanings given in Table B.
  • Table 7 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .7 and R 1 has one of the meanings given in Table B.
  • Table 8 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .8 and R 1 has one of the meanings given in Table B.
  • Table 9 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .9 and R 1 has one of the meanings given in Table B.
  • Table 10 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .10 and R 1 has one of the meanings given in Table B.
  • Table 1 1 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 1 and R 1 has one of the meanings given in Table B.
  • Table 12 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .12 and R 1 has one of the meanings given in Table B.
  • Table 13 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .13 and R 1 has one of the meanings given in Table B.
  • Table 14 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .14 and R 1 has one of the meanings given in Table B.
  • Table 15 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .15 and R 1 has one of the meanings given in Table B.
  • Table 16 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .16 and R 1 has one of the meanings given in Table B.
  • Table 17 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .17 and R 1 has one of the meanings given in Table B.
  • Table 18 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .18 and R 1 has one of the meanings given in Table B.
  • Table 19 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .19 and R 1 has one of the meanings given in Table B.
  • Table 20 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .20 and R 1 has one of the meanings given in Table B.
  • Table 21 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .21 and R 1 has one of the meanings given in Table B.
  • Table 22 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .22 and R 1 has one of the meanings given in Table B.
  • Table 23 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .23 and R 1 has one of the meanings given in Table B.
  • Table 24 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .24 and R 1 has one of the meanings given in Table B.
  • Table 25 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .25 and R 1 has one of the meanings given in Table B.
  • Table 26 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .26 and R 1 has one of the meanings given in Table B.
  • Table 27 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .27 and R 1 has one of the meanings given in Table B.
  • Table 28 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .28 and R 1 has one of the meanings given in Table B.
  • Table 29 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .29 and R 1 has one of the meanings given in Table B.
  • Table 30 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .30 and R 1 has one of the meanings given in Table B.
  • Table 31 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .31 and R 1 has one of the meanings given in Table B.
  • Table 32 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .32 and R 1 has one of the meanings given in Table B.
  • Table 33 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .33 and R 1 has one of the meanings given in Table B.
  • Table 34 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .34 and R 1 has one of the meanings given in Table B.
  • Table 35 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .35 and R 1 has one of the meanings given in Table B.
  • Table 36 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .36 and R 1 has one of the meanings given in Table B.
  • Table 37 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .37 and R 1 has one of the meanings given in Table B.
  • Table 38 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .38 and R 1 has one of the meanings given in Table B.
  • Table 39 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .39 and R 1 has one of the meanings given in Table B.
  • Table 40 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .40 and R 1 has one of the meanings given in Table B.
  • Table 41 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .41 and R 1 has one of the meanings given in Table B.
  • Table 42 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .42 and R 1 has one of the meanings given in Table B.
  • Table 43 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .43 and R 1 has one of the meanings given in Table B.
  • Table 44 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .44 and R 1 has one of the meanings given in Table B.
  • Table 45 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .45 and R 1 has one of the meanings given in Table B.
  • Table 46 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .46 and R 1 has one of the meanings given in Table B.
  • Table 47 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .47 and R 1 has one of the meanings given in Table B.
  • Table 48 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .48 and R 1 has one of the meanings given in Table B.
  • Table 49 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .49 and R 1 has one of the meanings given in Table B.
  • Table 50 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .50 and R 1 has one of the meanings given in Table B.
  • Table 51 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .51 and R 1 has one of the meanings given in Table B.
  • Table 52 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .52 and R 1 has one of the meanings given in Table B.
  • Table 53 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .53 and R 1 has one of the meanings given in Table B.
  • Table 54 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .54 and R 1 has one of the meanings given in Table B.
  • Table 55 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .55 and R 1 has one of the meanings given in Table B.
  • Table 56 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .56 and R 1 has one of the meanings given in Table B.
  • Table 57 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .57 and R 1 has one of the meanings given in Table B.
  • Table 58 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .58 and R 1 has one of the meanings given in Table B.
  • Table 59 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .59 and R 1 has one of the meanings given in Table B.
  • Table 60 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N- ⁇ oxides and the salts of their N-oxides, wherein A is a radical A-1 .60 and R 1 has one of the meanings given in Table B.
  • Table 61 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .61 and R 1 has one of the meanings given in Table B.
  • Table 62 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .62 and R 1 has one of the meanings given in Table B.
  • Table 63 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .63 and R 1 has one of the meanings given in Table B.
  • Table 64 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .64 and R 1 has one of the meanings given in Table B.
  • Table 65 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .65 and R 1 has one of the meanings given in Table B.
  • Table 66 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .66 and R 1 has one of the meanings given in Table B.
  • Table 67 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .67 and R 1 has one of the meanings given in Table B.
  • Table 68 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .68 and R 1 has one of the meanings given in Table B.
  • Table 69 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .69 and R 1 has one of the meanings given in Table B.
  • Table 70 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .70 and R 1 has one of the meanings given in Table B.
  • Table 71 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .71 and R 1 has one of the meanings given in Table B.
  • Table 72 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .72 and R 1 has one of the meanings given in Table B.
  • Table 73 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .73 and R 1 has one of the meanings given in Table B.
  • Table 74 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .74 and R 1 has one of the meanings given in Table B.
  • Table 75 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .75 and R 1 has one of the meanings given in Table B.
  • Table 76 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .76 and R 1 has one of the meanings given in Table B.
  • Table 77 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .77 and R 1 has one of the meanings given in Table B.
  • Table 78 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .78 and R 1 has one of the meanings given in Table B.
  • Table 79 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .79 and R 1 has one of the meanings given in Table B.
  • Table 80 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .80 and R 1 has one of the meanings given in Table B.
  • Table 81 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .81 and R 1 has one of the meanings given in Table B.
  • Table 82 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .82 and R 1 has one of the meanings given in Table B.
  • Table 83 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .83 and R 1 has one of the meanings given in Table B.
  • Table 84 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .84 and R 1 has one of the meanings given in Table B.
  • Table 85 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .85 and R 1 has one of the meanings given in Table B.
  • Table 86 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .86 and R 1 has one of the meanings given in Table B.
  • Table 87 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .87 and R 1 has one of the meanings given in Table B.
  • Table 88 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .88 and R 1 has one of the meanings given in Table B.
  • Table 89 Compounds of the formulae ⁇ . ⁇ and I '.B, and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .89 and R 1 has one of the meanings given in Table B.
  • Table 90 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .90 and R 1 has one of the meanings given in Table B.
  • Table 91 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .91 and R 1 has one of the meanings given in Table B.
  • Table 92 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .92 and R 1 has one of the meanings given in Table B.
  • Table 93 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .93 and R 1 has one of the meanings given in Table B.
  • Table 94 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .94 and R 1 has one of the meanings given in Table B.
  • Table 95 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .95 and R 1 has one of the meanings given in Table B.
  • Table 96 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .96 and R 1 has one of the meanings given in Table B.
  • Table 97 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .97 and R 1 has one of the meanings given in Table B.
  • Table 98 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .98 and R 1 has one of the meanings given in Table B.
  • Table 99 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .99 and R 1 has one of the meanings given in Table B.
  • Table 100 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .100 and R 1 has one of the meanings given in Table B.
  • Table 101 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .101 and R 1 has one of the meanings given in Table B.
  • Table 102 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .102 and R 1 has one of the meanings given in Table B.
  • Table 103 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .103 and R 1 has one of the meanings given in Table B.
  • Table 104 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .104 and R 1 has one of the meanings given in Table B.
  • Table 105 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .105 and R 1 has one of the meanings given in Table B.
  • Table 106 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .106 and R 1 has one of the meanings given in Table B.
  • Table 107 Compounds of the formulae I'.A and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .107 and R 1 has one of the meanings given in Table B.
  • Table 108 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .108 and R 1 has one of the meanings given in Table B.
  • Table 109 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .109 and R 1 has one of the meanings given in Table B.
  • Table 1 10 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 10 and R 1 has one of the meanings given in Table B.
  • Table 1 1 1 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 1 1 and R 1 has one of the meanings given in Table B.
  • Table 1 12 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 12 and R 1 has one of the meanings given in Table B.
  • Table 1 13 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 13 and R 1 has one of the meanings given in Table B.
  • Table 1 14 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 14 and R 1 has one of the meanings given in Table B.
  • Table 1 15 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 15 and R 1 has one of the meanings given in Table B.
  • Table 1 16 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 16 and R 1 has one of the meanings given in Table B.
  • Table 1 17 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 17 and R 1 has one of the meanings given in Table B.
  • Table 1 18 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 18 and R 1 has one of the meanings given in Table B.
  • Table 1 19 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .1 19 and R 1 has one of the meanings given in Table B.
  • Table 120 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .120 and R 1 has one of the meanings given in Table B.
  • Table 121 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .121 and R 1 has one of the meanings given in Table B.
  • Table 122 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .122 and R 1 has one of the meanings given in Table B.
  • Table 123 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .123 and R 1 has one of the meanings given in Table B.
  • Table 124 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .124 and R 1 has one of the meanings given in Table B.
  • Table 125 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .125 and R 1 has one of the meanings given in Table B.
  • Table 126 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .126 and R 1 has one of the meanings given in Table B.
  • Table 127 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .127 and R 1 has one of the meanings given in Table B.
  • Table 128 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .128 and R 1 has one of the meanings given in Table B.
  • Table 129 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .129 and R 1 has one of the meanings given in Table B.
  • Table 130 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .130 and R 1 has one of the meanings given in Table B.
  • Table 131 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .131 and R 1 has one of the meanings given in Table B.
  • Table 132 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .132 and R 1 has one of the meanings given in Table B.
  • Table 133 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .133 and R 1 has one of the meanings given in Table B.
  • Table 134 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .134 and R 1 has one of the meanings given in Table B.
  • Table 135 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .135 and R 1 has one of the meanings given in Table B.
  • Table 136 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .136 and R 1 has one of the meanings given in Table B.
  • Table 137 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .137 and R 1 has one of the meanings given in Table B.
  • Table 138 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .138 and R 1 has one of the meanings given in Table B.
  • Table 139 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .139 and R 1 has one of the meanings given in Table B.
  • Table 140 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .140 and R 1 has one of the meanings given in Table B.
  • Table 141 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .141 and R 1 has one of the meanings given in Table B.
  • Table 142 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .142 and R 1 has one of the meanings given in Table B.
  • Table 143 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .143 and R 1 has one of the meanings given in Table B.
  • Table 144 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .144 and R 1 has one of the meanings given in Table B.
  • Table 145 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .145 and R 1 has one of the meanings given in Table B.
  • Table 146 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .146 and R 1 has one of the meanings given in Table B.
  • Table 147 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .147 and R 1 has one of the meanings given in Table B.
  • Table 148 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .148 and R 1 has one of the meanings given in Table B.
  • Table 149 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .149 and R 1 has one of the meanings given in Table B.
  • Table 150 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .150 and R 1 has one of the meanings given in Table B.
  • Table 151 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .151 and R 1 has one of the meanings given in Table B.
  • Table 152 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .152 and R 1 has one of the meanings given in Table B.
  • Table 153 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .153 and R 1 has one of the meanings given in Table B.
  • Table 154 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .154 and R 1 has one of the meanings given in Table B.
  • Table 155 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .155 and R 1 has one of the meanings given in Table B.
  • Table 156 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .156 and R 1 has one of the meanings given in Table B.
  • Table 157 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .157 and R 1 has one of the meanings given in Table B.
  • Table 158 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .158 and R 1 has one of the meanings given in Table B.
  • Table 159 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .159 and R 1 has one of the meanings given in Table B.
  • Table 160 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .160 and R 1 has one of the meanings given in Table B.
  • Table 161 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .161 and R 1 has one of the meanings given in Table B.
  • Table 162 Compounds of the formulae I'.A and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .162 and R 1 has one of the meanings given in Table B.
  • Table 163 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .163 and R 1 has one of the meanings given in Table B.
  • Table 164 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .164 and R 1 has one of the meanings given in Table B.
  • Table 165 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .165 and R 1 has one of the meanings given in Table B.
  • Table 166 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .166 and R 1 has one of the meanings given in Table B.
  • Table 167 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .167 and R 1 has one of the meanings given in Table B.
  • Table 168 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .168 and R 1 has one of the meanings given in Table B.
  • Table 169 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .169 and R 1 has one of the meanings given in Table B.
  • Table 170 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .170 and R 1 has one of the meanings given in Table B.
  • Table 171 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .171 and R 1 has one of the meanings given in Table B.
  • Table 172 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .172 and R 1 has one of the meanings given in Table B.
  • Table 173 Compounds of the formulae I'.A and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-1 .173 and R 1 has one of the meanings given in Table B.
  • Table 174 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.1 and R 1 has one of the meanings given in Table B.
  • Table 175 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.2 and R 1 has one of the meanings given in Table B.
  • Table 176 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.3 and R 1 has one of the meanings given in Table B.
  • Table 177 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.4 and R 1 has one of the meanings given in Table B.
  • Table 178 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.5 and R 1 has one of the meanings given in Table B.
  • Table 179 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.6 and R 1 has one of the meanings given in Table B.
  • Table 180 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.7 and R 1 has one of the meanings given in Table B.
  • Table 181 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.8 and R 1 has one of the meanings given in Table B.
  • Table 182 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.9 and R 1 has one of the meanings given in Table B.
  • Table 183 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.10 and R 1 has one of the meanings given in Table B.
  • Table 184 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.1 1 and R 1 has one of the meanings given in Table B.
  • Table 185 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.12 and R 1 has one of the meanings given in Table B.
  • Table 186 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.13 and R 1 has one of the meanings given in Table B.
  • Table 187 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.14 and R 1 has one of the meanings given in Table B.
  • Table 188 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.15 and R 1 has one of the meanings given in Table B.
  • Table 189 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.16 and R 1 has one of the meanings given in Table B.
  • Table 190 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.17 and R 1 has one of the meanings given in Table B.
  • Table 191 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.18 and R 1 has one of the meanings given in Table B.
  • Table 192 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.19 and R 1 has one of the meanings given in Table B.
  • Table 193 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.20 and R 1 has one of the meanings given in Table B.
  • Table 194 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.21 and R 1 has one of the meanings given in Table B.
  • Table 195 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.22 and R 1 has one of the meanings given in Table B.
  • Table 196 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.23 and R 1 has one of the meanings given in Table B.
  • Table 197 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.24 and R 1 has one of the meanings given in Table B.
  • Table 198 Compounds of the formulae I'.A and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.25 and R 1 has one of the meanings given in Table B.
  • Table 199 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.26 and R 1 has one of the meanings given in Table B.
  • Table 200 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.27 and R 1 has one of the meanings given in Table B.
  • Table 201 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.28 and R 1 has one of the meanings given in Table B.
  • Table 202 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.29 and R 1 has one of the meanings given in Table B.
  • Table 203 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.30 and R 1 has one of the meanings given in Table B.
  • Table 204 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.31 and R 1 has one of the meanings given in Table B.
  • Table 205 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.32 and R 1 has one of the meanings given in Table B.
  • Table 206 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.33 and R 1 has one of the meanings given in Table B.
  • Table 207 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.34 and R 1 has one of the meanings given in Table B.
  • Table 208 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.35 and R 1 has one of the meanings given in Table B.
  • Table 209 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.36 and R 1 has one of the meanings given in Table B.
  • Table 210 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.37 and R 1 has one of the meanings given in Table B.
  • Table 21 1 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.38 and R 1 has one of the meanings given in Table B.
  • Table 212 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.39 and R 1 has one of the meanings given in Table B.
  • Table 213 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.40 and R 1 has one of the meanings given in Table B.
  • Table 214 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.41 and R 1 has one of the meanings given in Table B.
  • Table 215 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.42 and R 1 has one of the meanings given in Table B.
  • Table 216 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.43 and R 1 has one of the meanings given in Table B.
  • Table 217 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.44 and R 1 has one of the meanings given in Table B.
  • Table 218 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.45 and R 1 has one of the meanings given in Table B.
  • Table 219 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.46 and R 1 has one of the meanings given in Table B.
  • Table 220 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.47 and R 1 has one of the meanings given in Table B.
  • Table 221 Compounds of the formulae ⁇ . ⁇ and ⁇ . ⁇ , and their salts, their N-oxides and the salts of their N-oxides, wherein A is a radical A-2.48 and R 1 has one of the meanings given in Table B.

Abstract

Cette invention concerne des composés de pyridazine de formules (I) ou (II) et leurs sels, leurs N-oxydes et les sels desdits N-oxydes. Dans les formules, le radical A est de formule (A), # indiquant le point d'attachement au reste des formules (I) ou (II), A1 est N ou C-RA1, A2 est N ou C-RA2, A3 est N ou C-RA3, A4 est N ou C-RA4 et A5 est N ou C-RA5, à condition qu'une ou deux des variables A1, A2, A3, A4 ou A5 soit/soient N ; RA1, RA5, si présents, sont H, un atome d'halogène, CN, NO2, un alkyle C1-C6, haloalkyle C1-C6 et autres ; RA2, RA4, si présents, sont H, un atome d'halogène, CN, NO2, un alkyle C1-C10, un haloalkyle C1-C10 et autres ; RA3, si présent, est H, un atome d'halogène, CN, NO2, un alkyle C1-C10, haloalkyle C1-C10 et autres ; W est N ou C-Rw et V est N ou C-Rv, à condition qu'une des variables W ou V soit N ; Rt et Rw, si présents, sont H, un atome d'halogène, un méthyle, haloalkyle C1-? et autres ; Ru et Rv, si présents, sont H, un atome d'halogène, un alkyle C1-C4, haloalkyle C1-C3 et autres ; X1 est S, O ou NR1a, R1a étant H, un alkyle C1-C10 et autres ; X2 est OR2a, NR2bR2c, S(O)mR2d, m étant 0, 1 ou 2, R2a est un alkyle C1-C4, haloalkyle C1-C4 et autres, R2b, R2c sont H, un alkyle C1-C4, haloalkyle C1-C4 et autres, ou R2b et R2c ensemble avec l'atome d'azote auquel ils sont liés forment un hétérocycle, et R2d est un alkyle C1-C4, haloalkyle C1-C4, cycloalkyle C3-C6 et autres ; et R1 est H, CN, un alkyle C1-C10 et autres. Cette invention concerne, en outre, une méthode pour lutter contre les ravageurs invertébrés, une méthode pour protéger le matériel de multiplication des plantes et/ou les plantes qui poussent à partir de celui-ci, le matériel de multiplication des plantes, comprenant au moins un composé selon la présente invention, une méthode pour traiter ou protéger un animal contre l'infestation ou l'infection par des parasites et une composition à visée agricole contenant au moins un composé selon la présente invention.
PCT/EP2011/054424 2010-03-23 2011-03-23 Composés de pyridazine pour lutter contre les ravageurs invertébrés WO2011117286A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES11709439.1T ES2589792T3 (es) 2010-03-23 2011-03-23 Compuestos de piridazina para el control de plagas de invertebrados
CN2011800150446A CN102812018A (zh) 2010-03-23 2011-03-23 用于防治无脊椎动物害虫的哒嗪化合物
BR112012023231A BR112012023231A2 (pt) 2010-03-23 2011-03-23 ''composição de piradazina, método para controlar pragas invertyebradas, método para proteger material de propaganda e/ou as plantas, material de propagação de planta e composição agrícola''
EP11709439.1A EP2550264B1 (fr) 2010-03-23 2011-03-23 COMPOSÉS PYRIDAZINE DESTINÉS À LA LUTTE CONTRE LES NUISIBLES & xA; INVERTÉBRÉS
JP2013500489A JP2013522347A (ja) 2010-03-23 2011-03-23 無脊椎有害生物を防除するためのピリダジン化合物
US13/634,899 US9040537B2 (en) 2010-03-23 2011-03-23 Pyridazine compounds for controlling invertebrate pests

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31644110P 2010-03-23 2010-03-23
US61/316,441 2010-03-23
EP10157418.4 2010-03-23
EP10157418 2010-03-23

Publications (1)

Publication Number Publication Date
WO2011117286A1 true WO2011117286A1 (fr) 2011-09-29

Family

ID=44062018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/054424 WO2011117286A1 (fr) 2010-03-23 2011-03-23 Composés de pyridazine pour lutter contre les ravageurs invertébrés

Country Status (6)

Country Link
US (1) US9040537B2 (fr)
EP (1) EP2550264B1 (fr)
JP (1) JP2013522347A (fr)
CN (1) CN102812018A (fr)
ES (1) ES2589792T3 (fr)
WO (1) WO2011117286A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609700B2 (en) 2010-09-13 2013-12-17 Basf Se Pyridine compounds for controlling invertebrate pests I
WO2014021468A1 (fr) * 2012-07-31 2014-02-06 住友化学株式会社 Composé amide
US8853214B2 (en) 2010-03-23 2014-10-07 Basf Se Pyridazine compounds for controlling invertebrate pests
US8937177B2 (en) 2010-03-23 2015-01-20 Basf Se Pyridazine compounds for controlling invertebrate pests

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10478257B2 (en) * 2017-02-02 2019-11-19 Ethicon Llc Robotic surgical tool, system, and method

Citations (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060084A (en) 1961-06-09 1962-10-23 Du Pont Improved homogeneous, readily dispersed, pesticidal concentrate
US3299566A (en) 1964-06-01 1967-01-24 Olin Mathieson Water soluble film containing agricultural chemicals
US3920442A (en) 1972-09-18 1975-11-18 Du Pont Water-dispersible pesticide aggregates
US4144050A (en) 1969-02-05 1979-03-13 Hoechst Aktiengesellschaft Micro granules for pesticides and process for their manufacture
US4172714A (en) 1976-12-20 1979-10-30 E. I. Du Pont De Nemours And Company Dry compactible, swellable herbicidal compositions and pellets produced therefrom
GB2095558A (en) 1981-03-30 1982-10-06 Avon Packers Ltd Formulation of agricultural chemicals
EP0242246A1 (fr) 1986-03-11 1987-10-21 Plant Genetic Systems N.V. Cellules végétales résistantes aux inhibiteurs de la synthétase de glutamine, produites par génie génétique
US4822779A (en) 1988-03-26 1989-04-18 Korea Research Institute Of Chemical Technology Phosphoric and thiophosphonic acid derivatives of 5-hydroxypyrazoles, compositions and use
EP0332579A2 (fr) 1988-03-09 1989-09-13 Ciba-Geigy Ag Méthode de protection de plantes contre des maladies
EP0374753A2 (fr) 1988-12-19 1990-06-27 American Cyanamid Company Toxines insecticides, gènes les codant, anticorps les liant, ainsi que cellules végétales et plantes transgéniques exprimant ces toxines
EP0392225A2 (fr) 1989-03-24 1990-10-17 Ciba-Geigy Ag Plantes transgéniques résistantes aux maladies
EP0427529A1 (fr) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Lectines larvicides, et résistance induite des plantes aux insectes
WO1991013546A1 (fr) 1990-03-12 1991-09-19 E.I. Du Pont De Nemours And Company Granules pesticides dispersibles ou solubles dans l'eau, obtenus a partir de liants thermo-actives
EP0451878A1 (fr) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modification de plantes par techniques de génie génétique pour combattre ou contrôler les insectes
EP0454621A2 (fr) 1990-04-23 1991-10-30 Ciba-Geigy Ag Composés nématocides
EP0462456A1 (fr) 1990-06-16 1991-12-27 Nihon Nohyaku Co., Ltd. Dérivés d'hydrazinecarboxamide, procédé pour leur préparation et leur utilisation
WO1992000377A1 (fr) 1990-06-25 1992-01-09 Monsanto Company Plantes tolerant le glyphosate
EP0480258A2 (fr) 1990-10-10 1992-04-15 Bayer Ag Utilisation de dérivés de l'acide nicotinique 2-mercapto pour la lutte contre endoparasites. Dérivés de l'acide nicotinique 2-mercapto et procédés pour leur préparation
US5180587A (en) 1988-06-28 1993-01-19 E. I. Du Pont De Nemours And Company Tablet formulations of pesticides
WO1993007278A1 (fr) 1991-10-04 1993-04-15 Ciba-Geigy Ag Sequence d'adn synthetique ayant une action insecticide accrue dans le mais
US5208030A (en) 1989-08-30 1993-05-04 Imperial Chemical Industries Plc Active ingredient dosage device
US5232701A (en) 1990-10-11 1993-08-03 Sumitomo Chemical Company, Limited Boron carbonate and solid acid pesticidal composition
WO1995034656A1 (fr) 1994-06-10 1995-12-21 Ciba-Geigy Ag Nouveaux genes du bacillus thuringiensis codant pour des toxines actives contre les lepidopteres
EP0707445A1 (fr) 1993-07-03 1996-04-24 Basf Ag Formulation aqueuse polyphasee et stable prete a l'emploi pour produits phytosanitaires et procede de preparation
US5559024A (en) 1988-03-23 1996-09-24 Rhone-Poulenc Agrochimie Chimeric nitrilase-encoding gene for herbicidal resistance
WO1997041218A1 (fr) 1996-04-29 1997-11-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Riz resistant aux herbicides
WO1998002527A1 (fr) 1996-07-17 1998-01-22 Michigan State University Plante de betterave a sucre resistant aux herbicides a base d'imidazolinone
WO1998002526A1 (fr) 1996-07-17 1998-01-22 Michigan State University Plante de betterave a sucre resistant aux herbicides a base d'imidazolinone
WO1998028279A1 (fr) 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie Derives pesticides de 1-arylpyrazole et de pyridylpyrazole
WO1998028277A1 (fr) 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie 1-arylpyrazoles pesticides
WO1998045274A1 (fr) 1997-04-07 1998-10-15 Mitsubishi Chemical Corporation Derives de pyrazole, leur procede de preparation, intermediaires et pesticide comprenant ces derives comme composant actif
WO2000026390A2 (fr) 1998-10-29 2000-05-11 American Cyanamid Company Genes et vecteurs servant a conferer une resistance aux herbicides aux plantes
WO2001000614A1 (fr) 1999-06-29 2001-01-04 Mitsubishi Chemical Corporation Derives de pyrazole, leur procede de production et pesticides les contenant comme principe actif
US6221890B1 (en) 1999-10-21 2001-04-24 Sumitomo Chemical Company Limited Acaricidal compositions
US6222100B1 (en) 1984-03-06 2001-04-24 Mgi Pharma, Inc. Herbicide resistance in plants
EP1097932A1 (fr) 1999-11-02 2001-05-09 Nihon Nohyaku Co., Ltd. Dérivés d'aminoquinazolinones (thiones) substituées ou leurs sels, leurs intermédiaires, pesticides et méthode pour leur utilisation
WO2001070671A2 (fr) 2000-03-22 2001-09-27 E.I. Du Pont De Nemours And Company Anthranilamides insecticides
US6300348B1 (en) 1996-04-03 2001-10-09 Bayer Aktiengesellschaft Pesticide for parasitic insects and acarids on humans
WO2001082685A1 (fr) 2000-04-28 2001-11-08 Basf Aktiengesellschaft Utilisation d'un gene ahas 2 de mais x112 mutant et d'herbicides d'imidazolinone pour la selection de monocotyledones transgeniques, plantes de mais, de riz et de ble resistantes aux herbicides d'imidazolinone
WO2002015701A2 (fr) 2000-08-25 2002-02-28 Syngenta Participations Ag Nouvelles toxines insecticides derivees de proteines cristallines insecticides de $i(bacillus thuringiensis)
JP2002193709A (ja) 2000-12-27 2002-07-10 Mitsubishi Chemicals Corp 殺虫・殺菌剤組成物
WO2002090321A1 (fr) 2001-05-09 2002-11-14 Sumitomo Chemical Company, Limited Composes de malononitrile et leur utilisation en tant que pesticides
WO2002094765A2 (fr) 2001-05-18 2002-11-28 Nihon Nohyaku Co., Ltd. Derive d'amide aromatique substitue, produit intermediaire de ce dernier, insecticide horticole contenant ces derniers et procedes d'utilisation de ces derniers
WO2003007718A1 (fr) 2001-07-11 2003-01-30 Sumitomo Chemical Company, Limited Procede relatif a la lutte contre les insectes nuisibles dans l'agriculture
WO2003007717A1 (fr) 2001-07-11 2003-01-30 Sumitomo Chemical Company, Limited Procede relatif a la lutte contre les insectes nuisibles dans l'agriculture
WO2003014357A1 (fr) 2001-08-09 2003-02-20 University Of Saskatchewan Plants de ble presentant une resistance accrue aux herbicides a base d'imidazolinone
WO2003014356A1 (fr) 2001-08-09 2003-02-20 University Of Saskatchewan Plants de ble presentant une resistance accrue aux herbicides a base d'imidazolinone
WO2003013225A2 (fr) 2001-08-09 2003-02-20 Northwest Plant Breeding Company Plants de ble presentant une resistance accrue aux herbicides a l'imidazolinone
WO2003015519A1 (fr) 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Anthranilamides arthropodicides
WO2003018810A2 (fr) 2001-08-31 2003-03-06 Syngenta Participations Ag Toxines cry3a modifiees et sequences d'acides nucleiques les codant
WO2003052073A2 (fr) 2001-12-17 2003-06-26 Syngenta Participations Ag Nouvel evenement du mais
WO2003086075A1 (fr) 2002-04-16 2003-10-23 Bayer Healthcare Ag Lutte antiparasitaire chez l'animal
WO2003106427A2 (fr) 2002-06-13 2003-12-24 E.I. Du Pont De Nemours And Company Insecticides de pyrazolecarboxamide
WO2004006677A1 (fr) 2002-07-17 2004-01-22 Sumitomo Chemical Company, Limited Composes de malononitrile et leur utilisation en tant que pesticides
WO2004016073A2 (fr) 2002-07-10 2004-02-26 The Department Of Agriculture, Western Australia Plants de ble presentant une resistance accrue a un herbicide a base d'imidazolinone
WO2004067528A1 (fr) 2003-01-28 2004-08-12 E.I. Du Pont De Nemours And Company Insecticides a base de cyano-anthranilamide
WO2004080180A1 (fr) 2003-03-12 2004-09-23 Otsuka Chemical Co., Ltd. Acaricide
WO2004106529A2 (fr) 2003-05-28 2004-12-09 Basf Aktiengesellschaft Plantes de ble presentant une tolerance accrue aux herbicides d'imidazolinone
WO2005020673A1 (fr) 2003-08-29 2005-03-10 Instituto Nacional De Technologia Agropecuaria Plants de riz presentant une tolerance accrue aux herbicides imidazolinone
WO2005063694A1 (fr) 2003-12-26 2005-07-14 Sumitomo Chemical Company, Limited Compose nitrile et son utilisation pour le controle des insectes et animaux nuisibles
WO2005068432A1 (fr) 2004-01-16 2005-07-28 Sumitomo Chemical Company, Limited Composes de malononitrile utilisables comme pesticides
WO2005068423A1 (fr) 2004-01-16 2005-07-28 Sumitomo Chemical Company, Limited Compose du manolonitrile et son utilisation
WO2005118552A2 (fr) 2004-04-13 2005-12-15 E.I. Dupont De Nemours And Company Insecticides a base d'anthranilamides
JP2006131529A (ja) 2004-11-05 2006-05-25 Sumitomo Chemical Co Ltd 有害生物防除組成物
WO2006060029A2 (fr) 2004-04-08 2006-06-08 Dow Agrosciences Llc Sulfoximines n-substituees insecticides
WO2007060839A1 (fr) 2005-11-22 2007-05-31 Sumitomo Chemical Company, Limited Composés organiques du soufre et utilisation de ceux-ci en tant qu'arthropodicides
WO2007068375A1 (fr) 2005-12-17 2007-06-21 Bayer Cropscience Ag Carboxamides pour lutter contre les micro-organismes indesirables dans la protection phytosanitaire
WO2007074789A1 (fr) 2005-12-26 2007-07-05 Nissan Chemical Industries, Ltd. Compose de 1,3-bis(phenyle substitue)-3-hydroxypropan-1-one ou 2-propen-1-one et son sel
WO2007083394A1 (fr) 2006-01-19 2007-07-26 Mitsui Chemicals, Inc. Composition pesticide contenant des derives de diamine
WO2007101540A1 (fr) 2006-03-06 2007-09-13 Bayer Cropscience Ag Combinaisons de principes actifs à propriétés insecticides
WO2007115644A1 (fr) 2006-03-31 2007-10-18 Bayer Cropscience Ag Composés énaminocarbonylés substitués
WO2007149134A1 (fr) 2006-06-23 2007-12-27 Dow Agrosciences Llc Procédé pour lutter contre des insectes résistant aux insecticides courants
JP2008115155A (ja) 2007-04-06 2008-05-22 Nippon Soda Co Ltd 有害生物防除剤組成物及び有害生物防除方法
WO2008066153A1 (fr) 2006-11-30 2008-06-05 Meiji Seika Kaisha, Ltd. Agent antiparasitaire
WO2008072743A1 (fr) 2006-12-15 2008-06-19 Ishihara Sangyo Kaisha, Ltd. Procédé de fabrication d'un composé d'anthranilamide par l'utilisation d'un nouveau composé de pyrazole en tant qu'intermédiaire
WO2008072783A1 (fr) 2006-12-14 2008-06-19 Ishihara Sangyo Kaisha, Ltd. Compositions pesticides
WO2008108491A1 (fr) 2007-03-08 2008-09-12 Meiji Seika Kaisha, Ltd. Composition de lutte contre les nuisibles
JP2009010907A (ja) 2007-05-25 2009-01-15 Shintaro Gomi アクティブコイル、アクティブコイルアンテナエレメント及びｌｃ共振回路並びにそれらを利用した放送用受信機。
WO2009027393A2 (fr) 2007-08-27 2009-03-05 Basf Se Composés de pyrazole permettant de lutter contre les nuisibles invertébrés
WO2010034738A2 (fr) * 2008-09-24 2010-04-01 Basf Se Composés pyrazoliques utilisables dans la lutte contre les invertébrés nuisibles
WO2010112177A1 (fr) * 2009-04-03 2010-10-07 Bayer Cropscience Aktiengesellschaft Amines pyridines et –pyridazines acylées en tant qu'insecticides
WO2011003796A1 (fr) * 2009-07-06 2011-01-13 Basf Se Composés pyridazine destinés à la lutte contre les nuisibles invertébrés
WO2011003793A1 (fr) * 2009-07-06 2011-01-13 Basf Se Composés pyridazine destinés à la lutte contre les nuisibles invertébrés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009154769A1 (fr) * 2008-06-19 2009-12-23 Xcovery, Inc. Composés de pyridazinecarboxamide substitués utiles en tant que composés inhibiteurs de kinase
CA2741649A1 (fr) * 2008-10-30 2010-05-06 Merck Sharp & Dohme Corp. Antagonistes des recepteurs de l'orexine a base de pyridazine-carboxamide
AU2011311814B2 (en) * 2010-10-08 2016-12-22 Xcovery Holdings, Inc. Substituted pyridazine carboxamide compounds

Patent Citations (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060084A (en) 1961-06-09 1962-10-23 Du Pont Improved homogeneous, readily dispersed, pesticidal concentrate
US3299566A (en) 1964-06-01 1967-01-24 Olin Mathieson Water soluble film containing agricultural chemicals
US4144050A (en) 1969-02-05 1979-03-13 Hoechst Aktiengesellschaft Micro granules for pesticides and process for their manufacture
US3920442A (en) 1972-09-18 1975-11-18 Du Pont Water-dispersible pesticide aggregates
US4172714A (en) 1976-12-20 1979-10-30 E. I. Du Pont De Nemours And Company Dry compactible, swellable herbicidal compositions and pellets produced therefrom
GB2095558A (en) 1981-03-30 1982-10-06 Avon Packers Ltd Formulation of agricultural chemicals
US6222100B1 (en) 1984-03-06 2001-04-24 Mgi Pharma, Inc. Herbicide resistance in plants
EP0451878A1 (fr) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modification de plantes par techniques de génie génétique pour combattre ou contrôler les insectes
EP0242246A1 (fr) 1986-03-11 1987-10-21 Plant Genetic Systems N.V. Cellules végétales résistantes aux inhibiteurs de la synthétase de glutamine, produites par génie génétique
EP0242236A1 (fr) 1986-03-11 1987-10-21 Plant Genetic Systems N.V. Cellules végétales résistantes aux inhibiteurs de la synthétase de glutamine, produites par génie génétique
EP0332579A2 (fr) 1988-03-09 1989-09-13 Ciba-Geigy Ag Méthode de protection de plantes contre des maladies
US5559024A (en) 1988-03-23 1996-09-24 Rhone-Poulenc Agrochimie Chimeric nitrilase-encoding gene for herbicidal resistance
US4822779A (en) 1988-03-26 1989-04-18 Korea Research Institute Of Chemical Technology Phosphoric and thiophosphonic acid derivatives of 5-hydroxypyrazoles, compositions and use
US5180587A (en) 1988-06-28 1993-01-19 E. I. Du Pont De Nemours And Company Tablet formulations of pesticides
EP0374753A2 (fr) 1988-12-19 1990-06-27 American Cyanamid Company Toxines insecticides, gènes les codant, anticorps les liant, ainsi que cellules végétales et plantes transgéniques exprimant ces toxines
EP0392225A2 (fr) 1989-03-24 1990-10-17 Ciba-Geigy Ag Plantes transgéniques résistantes aux maladies
US5208030A (en) 1989-08-30 1993-05-04 Imperial Chemical Industries Plc Active ingredient dosage device
EP0427529A1 (fr) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Lectines larvicides, et résistance induite des plantes aux insectes
WO1991013546A1 (fr) 1990-03-12 1991-09-19 E.I. Du Pont De Nemours And Company Granules pesticides dispersibles ou solubles dans l'eau, obtenus a partir de liants thermo-actives
EP0454621A2 (fr) 1990-04-23 1991-10-30 Ciba-Geigy Ag Composés nématocides
EP0462456A1 (fr) 1990-06-16 1991-12-27 Nihon Nohyaku Co., Ltd. Dérivés d'hydrazinecarboxamide, procédé pour leur préparation et leur utilisation
WO1992000377A1 (fr) 1990-06-25 1992-01-09 Monsanto Company Plantes tolerant le glyphosate
EP0480258A2 (fr) 1990-10-10 1992-04-15 Bayer Ag Utilisation de dérivés de l'acide nicotinique 2-mercapto pour la lutte contre endoparasites. Dérivés de l'acide nicotinique 2-mercapto et procédés pour leur préparation
US5232701A (en) 1990-10-11 1993-08-03 Sumitomo Chemical Company, Limited Boron carbonate and solid acid pesticidal composition
WO1993007278A1 (fr) 1991-10-04 1993-04-15 Ciba-Geigy Ag Sequence d'adn synthetique ayant une action insecticide accrue dans le mais
EP0707445A1 (fr) 1993-07-03 1996-04-24 Basf Ag Formulation aqueuse polyphasee et stable prete a l'emploi pour produits phytosanitaires et procede de preparation
WO1995034656A1 (fr) 1994-06-10 1995-12-21 Ciba-Geigy Ag Nouveaux genes du bacillus thuringiensis codant pour des toxines actives contre les lepidopteres
US6300348B1 (en) 1996-04-03 2001-10-09 Bayer Aktiengesellschaft Pesticide for parasitic insects and acarids on humans
WO1997041218A1 (fr) 1996-04-29 1997-11-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Riz resistant aux herbicides
WO1998002527A1 (fr) 1996-07-17 1998-01-22 Michigan State University Plante de betterave a sucre resistant aux herbicides a base d'imidazolinone
WO1998002526A1 (fr) 1996-07-17 1998-01-22 Michigan State University Plante de betterave a sucre resistant aux herbicides a base d'imidazolinone
WO1998028279A1 (fr) 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie Derives pesticides de 1-arylpyrazole et de pyridylpyrazole
WO1998028277A1 (fr) 1996-12-24 1998-07-02 Rhone-Poulenc Agrochimie 1-arylpyrazoles pesticides
WO1998045274A1 (fr) 1997-04-07 1998-10-15 Mitsubishi Chemical Corporation Derives de pyrazole, leur procede de preparation, intermediaires et pesticide comprenant ces derives comme composant actif
US6335357B1 (en) 1997-04-07 2002-01-01 Mitsubishi Chemical Corporation Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient
WO2000026390A2 (fr) 1998-10-29 2000-05-11 American Cyanamid Company Genes et vecteurs servant a conferer une resistance aux herbicides aux plantes
WO2001000614A1 (fr) 1999-06-29 2001-01-04 Mitsubishi Chemical Corporation Derives de pyrazole, leur procede de production et pesticides les contenant comme principe actif
US6221890B1 (en) 1999-10-21 2001-04-24 Sumitomo Chemical Company Limited Acaricidal compositions
EP1097932A1 (fr) 1999-11-02 2001-05-09 Nihon Nohyaku Co., Ltd. Dérivés d'aminoquinazolinones (thiones) substituées ou leurs sels, leurs intermédiaires, pesticides et méthode pour leur utilisation
WO2001070671A2 (fr) 2000-03-22 2001-09-27 E.I. Du Pont De Nemours And Company Anthranilamides insecticides
WO2001082685A1 (fr) 2000-04-28 2001-11-08 Basf Aktiengesellschaft Utilisation d'un gene ahas 2 de mais x112 mutant et d'herbicides d'imidazolinone pour la selection de monocotyledones transgeniques, plantes de mais, de riz et de ble resistantes aux herbicides d'imidazolinone
WO2002015701A2 (fr) 2000-08-25 2002-02-28 Syngenta Participations Ag Nouvelles toxines insecticides derivees de proteines cristallines insecticides de $i(bacillus thuringiensis)
JP2002193709A (ja) 2000-12-27 2002-07-10 Mitsubishi Chemicals Corp 殺虫・殺菌剤組成物
WO2002090321A1 (fr) 2001-05-09 2002-11-14 Sumitomo Chemical Company, Limited Composes de malononitrile et leur utilisation en tant que pesticides
WO2002089579A1 (fr) 2001-05-09 2002-11-14 Sumitomo Chemical Company, Limited Composition pesticide comprenant des composes de malononitrile
WO2002090320A2 (fr) 2001-05-09 2002-11-14 Sumitomo Chemical Company, Limited Composes de malononitrile et leur utilisation en tant que pesticides
WO2002094765A2 (fr) 2001-05-18 2002-11-28 Nihon Nohyaku Co., Ltd. Derive d'amide aromatique substitue, produit intermediaire de ce dernier, insecticide horticole contenant ces derniers et procedes d'utilisation de ces derniers
WO2003007718A1 (fr) 2001-07-11 2003-01-30 Sumitomo Chemical Company, Limited Procede relatif a la lutte contre les insectes nuisibles dans l'agriculture
WO2003007717A1 (fr) 2001-07-11 2003-01-30 Sumitomo Chemical Company, Limited Procede relatif a la lutte contre les insectes nuisibles dans l'agriculture
WO2003014357A1 (fr) 2001-08-09 2003-02-20 University Of Saskatchewan Plants de ble presentant une resistance accrue aux herbicides a base d'imidazolinone
WO2003014356A1 (fr) 2001-08-09 2003-02-20 University Of Saskatchewan Plants de ble presentant une resistance accrue aux herbicides a base d'imidazolinone
WO2003013225A2 (fr) 2001-08-09 2003-02-20 Northwest Plant Breeding Company Plants de ble presentant une resistance accrue aux herbicides a l'imidazolinone
WO2003015519A1 (fr) 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Anthranilamides arthropodicides
WO2003018810A2 (fr) 2001-08-31 2003-03-06 Syngenta Participations Ag Toxines cry3a modifiees et sequences d'acides nucleiques les codant
WO2003052073A2 (fr) 2001-12-17 2003-06-26 Syngenta Participations Ag Nouvel evenement du mais
WO2003086075A1 (fr) 2002-04-16 2003-10-23 Bayer Healthcare Ag Lutte antiparasitaire chez l'animal
WO2003106427A2 (fr) 2002-06-13 2003-12-24 E.I. Du Pont De Nemours And Company Insecticides de pyrazolecarboxamide
WO2004016073A2 (fr) 2002-07-10 2004-02-26 The Department Of Agriculture, Western Australia Plants de ble presentant une resistance accrue a un herbicide a base d'imidazolinone
WO2004006677A1 (fr) 2002-07-17 2004-01-22 Sumitomo Chemical Company, Limited Composes de malononitrile et leur utilisation en tant que pesticides
WO2004067528A1 (fr) 2003-01-28 2004-08-12 E.I. Du Pont De Nemours And Company Insecticides a base de cyano-anthranilamide
WO2004080180A1 (fr) 2003-03-12 2004-09-23 Otsuka Chemical Co., Ltd. Acaricide
WO2004106529A2 (fr) 2003-05-28 2004-12-09 Basf Aktiengesellschaft Plantes de ble presentant une tolerance accrue aux herbicides d'imidazolinone
WO2005020673A1 (fr) 2003-08-29 2005-03-10 Instituto Nacional De Technologia Agropecuaria Plants de riz presentant une tolerance accrue aux herbicides imidazolinone
WO2005063694A1 (fr) 2003-12-26 2005-07-14 Sumitomo Chemical Company, Limited Compose nitrile et son utilisation pour le controle des insectes et animaux nuisibles
WO2005068423A1 (fr) 2004-01-16 2005-07-28 Sumitomo Chemical Company, Limited Compose du manolonitrile et son utilisation
WO2005068432A1 (fr) 2004-01-16 2005-07-28 Sumitomo Chemical Company, Limited Composes de malononitrile utilisables comme pesticides
WO2006060029A2 (fr) 2004-04-08 2006-06-08 Dow Agrosciences Llc Sulfoximines n-substituees insecticides
WO2005118552A2 (fr) 2004-04-13 2005-12-15 E.I. Dupont De Nemours And Company Insecticides a base d'anthranilamides
JP2006131529A (ja) 2004-11-05 2006-05-25 Sumitomo Chemical Co Ltd 有害生物防除組成物
WO2007060839A1 (fr) 2005-11-22 2007-05-31 Sumitomo Chemical Company, Limited Composés organiques du soufre et utilisation de ceux-ci en tant qu'arthropodicides
WO2007068375A1 (fr) 2005-12-17 2007-06-21 Bayer Cropscience Ag Carboxamides pour lutter contre les micro-organismes indesirables dans la protection phytosanitaire
WO2007074789A1 (fr) 2005-12-26 2007-07-05 Nissan Chemical Industries, Ltd. Compose de 1,3-bis(phenyle substitue)-3-hydroxypropan-1-one ou 2-propen-1-one et son sel
WO2007083394A1 (fr) 2006-01-19 2007-07-26 Mitsui Chemicals, Inc. Composition pesticide contenant des derives de diamine
WO2007101540A1 (fr) 2006-03-06 2007-09-13 Bayer Cropscience Ag Combinaisons de principes actifs à propriétés insecticides
WO2007115644A1 (fr) 2006-03-31 2007-10-18 Bayer Cropscience Ag Composés énaminocarbonylés substitués
WO2007149134A1 (fr) 2006-06-23 2007-12-27 Dow Agrosciences Llc Procédé pour lutter contre des insectes résistant aux insecticides courants
WO2008066153A1 (fr) 2006-11-30 2008-06-05 Meiji Seika Kaisha, Ltd. Agent antiparasitaire
WO2008072783A1 (fr) 2006-12-14 2008-06-19 Ishihara Sangyo Kaisha, Ltd. Compositions pesticides
WO2008072743A1 (fr) 2006-12-15 2008-06-19 Ishihara Sangyo Kaisha, Ltd. Procédé de fabrication d'un composé d'anthranilamide par l'utilisation d'un nouveau composé de pyrazole en tant qu'intermédiaire
WO2008108491A1 (fr) 2007-03-08 2008-09-12 Meiji Seika Kaisha, Ltd. Composition de lutte contre les nuisibles
JP2008115155A (ja) 2007-04-06 2008-05-22 Nippon Soda Co Ltd 有害生物防除剤組成物及び有害生物防除方法
JP2009010907A (ja) 2007-05-25 2009-01-15 Shintaro Gomi アクティブコイル、アクティブコイルアンテナエレメント及びｌｃ共振回路並びにそれらを利用した放送用受信機。
WO2009027393A2 (fr) 2007-08-27 2009-03-05 Basf Se Composés de pyrazole permettant de lutter contre les nuisibles invertébrés
WO2010034738A2 (fr) * 2008-09-24 2010-04-01 Basf Se Composés pyrazoliques utilisables dans la lutte contre les invertébrés nuisibles
WO2010112177A1 (fr) * 2009-04-03 2010-10-07 Bayer Cropscience Aktiengesellschaft Amines pyridines et –pyridazines acylées en tant qu'insecticides
WO2011003796A1 (fr) * 2009-07-06 2011-01-13 Basf Se Composés pyridazine destinés à la lutte contre les nuisibles invertébrés
WO2011003793A1 (fr) * 2009-07-06 2011-01-13 Basf Se Composés pyridazine destinés à la lutte contre les nuisibles invertébrés

Non-Patent Citations (31)

* Cited by examiner, † Cited by third party
Title
"Agro Project", November 2004, PJB PUBLICATIONS LTD
"Farm Chemicals Handbook", vol. 88, 2001, MEISTER PUBLISHING COMPANY
"Perry's Chemical Engineer's Handbook", 1963, MCGRAW-HILL, pages: 8 - 57
"The Pesticide Manual", 2003, BRITISH CROP PROTECTION COUNCIL
B. BELLEAU; G. MALEK, J. AMER. CHEM. SOC., vol. 90, 1968, pages 1651
B. CASTRO; J.R. DOMOY; G. EVIN; C. SELVE, TETRAHEDRON LETT., vol. 14, 1975, pages 1219
BIOCONJUG. CHEM., vol. 16, no. 1, January 2005 (2005-01-01), pages 113 - 21
BIOMATERIALS, vol. 22, no. 5, March 2001 (2001-03-01), pages 405 - 17
BIOTECHNOL PROG., vol. 17, no. 4, July 2001 (2001-07-01), pages 720 - 8
BROWNING: "Agglomeration", CHEMICAL ENGINEERING, 4 December 1967 (1967-12-04), pages 147 - 48
C. BOTTEGHI ET AL., JOURNAL OF ORGANOMETALLIC CHEMISTRY, vol. 370, 1989, pages 17 - 31
CURR. OPIN. CHEM. BIOL., vol. 10, no. 5, 28 August 2006 (2006-08-28), pages 487 - 91
D. A. KNOWLES: "Chemistry and Technology of Agrochemical Formulations", 1998, KLUWER ACADEMIC PUBLISHERS
HANCE ET AL.: "Weed Control Handbook", 1989, BLACKWELL SCIENTIFIC PUBLICATIONS
HEINISCH ET AL., J. HETEROCYCLIC CHEMISTRY, vol. 38, 2001, pages 125 - 130
HEINISCH G ET AL: "PYRIDAZINES 89. ON THE SYNTHESIS OF NOVEL 1,2-DIAZINE CONTAINING TRICYCLIC SYSTEMS: PREPARATION OF DIPYRIDAZINODIAZEPINONES", HETEROCYCLES, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 51, no. 5, 1 January 1999 (1999-01-01), pages 1035 - 1050, XP001019151, ISSN: 0385-5414 *
HETEROCYCLES, vol. 51, 1999, pages 1035 - 1050
HOUBEN-WEYL: "Methoden der organ. Chemie", vol. E5, 1985, GEORG-THIEME-VERLAG, pages: 941 - 1045
J. COSTE ET AL., TETRAHEDRON LETT., vol. 31, 1990, pages 205
J. DIAGO-MESEQUER, SYNTHESIS, 1980, pages 547
J.C. SHEEHAN; G.P. HESS, J. AM. CHEM. SOC., vol. 77, 1955, pages 1067
KLINGMAN: "Weed Control as a Science", 1961, JOHN WILEY AND SONS, INC.
M. JESBER- GER ET AL., SYNTHESIS, 2003, pages 1929
MOLLET, H., GRUBEMANN, A.: "Formulation technology", 2001, WILEY VCH VERLAG GMBH
NAT. PROTOC., vol. 2, no. 5, 2007, pages 1225 - 35
PESTICIDE SCIENCE, vol. 54, 1988, pages 237 - 243
PROTEIN ENG. DES. SEL., vol. 17, no. 1, January 2004 (2004-01-01), pages 57 - 66
R. KNORR; A. TRZECIAK; W. BANNWARTH; D. GILLESSEN, TETRAHEDRON LETT., vol. 30, 1989, pages 1927
S. CHEN; J. XU, TETRAHEDRON LETT., vol. 33, 1992, pages 647
V. GLUSHKOV ET AL., PHARMACEUTICAL CHEMISTRY JOURNAL, vol. 39, no. 10, 2005, pages 533 - 536
Y. KISO; H. YAJIMA, J. CHEM. SOC., CHEM. COMMUN., 1972, pages 942

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853214B2 (en) 2010-03-23 2014-10-07 Basf Se Pyridazine compounds for controlling invertebrate pests
US8937177B2 (en) 2010-03-23 2015-01-20 Basf Se Pyridazine compounds for controlling invertebrate pests
US8609700B2 (en) 2010-09-13 2013-12-17 Basf Se Pyridine compounds for controlling invertebrate pests I
WO2014021468A1 (fr) * 2012-07-31 2014-02-06 住友化学株式会社 Composé amide
CN104507911A (zh) * 2012-07-31 2015-04-08 住友化学株式会社 酰胺化合物
JPWO2014021468A1 (ja) * 2012-07-31 2016-07-21 住友化学株式会社 アミド化合物

Also Published As

Publication number Publication date
US9040537B2 (en) 2015-05-26
JP2013522347A (ja) 2013-06-13
US20130012380A1 (en) 2013-01-10
CN102812018A (zh) 2012-12-05
EP2550264A1 (fr) 2013-01-30
ES2589792T3 (es) 2016-11-16
EP2550264B1 (fr) 2016-06-08

Similar Documents

Publication Publication Date Title
US9375008B2 (en) Pyrazole compounds for controlling invertebrate pests
US8853125B2 (en) Pyrazole compounds for controlling invertebrate pests
US9204647B2 (en) Pyrazole compounds for controlling invertebrate pests
EP2451808B1 (fr) Composés pyridazine destinés à la lutte contre les nuisibles invertébrés
EP2451804B1 (fr) Composés pyridazine destinés à la lutte contre les nuisibles invertébrés
EP2456308A2 (fr) Composés dérivés de pyridine pour le côntrole des animaux nuisibles invertébrés
US10206401B2 (en) Pyridine compounds for controlling invertebrate pests II
EP2550264B1 (fr) COMPOSÉS PYRIDAZINE DESTINÉS À LA LUTTE CONTRE LES NUISIBLES & xA; INVERTÉBRÉS
WO2012034959A2 (fr) Composés de pyridine pour la lutte contre les nuisibles invertébrés

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180015044.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11709439

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 13634899

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2013500489

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011709439

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012023231

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012023231

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120914